0001493152-18-000494.txt : 20180112 0001493152-18-000494.hdr.sgml : 20180112 20180112145250 ACCESSION NUMBER: 0001493152-18-000494 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 55 CONFORMED PERIOD OF REPORT: 20171130 FILED AS OF DATE: 20180112 DATE AS OF CHANGE: 20180112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novo Integrated Sciences, Inc. CENTRAL INDEX KEY: 0001138978 STANDARD INDUSTRIAL CLASSIFICATION: ENGINES & TURBINES [3510] IRS NUMBER: 593691650 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-109118 FILM NUMBER: 18525741 BUSINESS ADDRESS: STREET 1: 11120 NE 2ND STREET STREET 2: SUITE 200 CITY: BELLEVUE STATE: WA ZIP: 98004 BUSINESS PHONE: (206) 617-9797 MAIL ADDRESS: STREET 1: 11120 NE 2ND STREET STREET 2: SUITE 200 CITY: BELLEVUE STATE: WA ZIP: 98004 FORMER COMPANY: FORMER CONFORMED NAME: TURBINE TRUCK ENGINES INC DATE OF NAME CHANGE: 20010420 10-Q 1 form10-q.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended November 30, 2017

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______, 20___, to _____, 20___.

 

Commission File Number 333-109118

 

Novo Integrated Sciences, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Nevada   59-3691650
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification Number)
     

11120 NE 2nd Street, Suite 200

Bellevue, Washington

  98004
(Address of Principal Executive Offices)   (Zip Code)

 

(206) 617-9797

(Registrant’s Telephone Number, Including Area Code)

 

N/A

 

(Former name or former address, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “accelerated filer,” “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer [  ] Accelerated filer [  ]
Non-accelerated filer [  ] Smaller reporting company [X]
(Do not check if a smaller reporting company)    
Emerging growth company [  ]    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Yes [  ] No [X]

 

There were 202,221,364 shares of the Registrant’s $0.001 par value common stock outstanding as of January 9, 2018.

 

 

 

 

 

 

Novo Integrated Sciences, Inc.

 

Contents

 

PART I – FINANCIAL INFORMATION 2
   
Item 1. Financial Statements 2
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation 15
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 22
     
Item 4. Controls and Procedures 22
     
PART II – OTHER INFORMATION 22
     
Item 1. Legal Proceedings 22
     
Item 1A. Risk Factors 23
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23
     
Item 3. Defaults Upon Senior Securities 23
     
Item 4. Mine Safety Disclosures 23
     
Item 5. Other Information 23
     
Item 6. Exhibits 24
     
Signatures 25

 

 

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

NOVO INTEGRATED SCIENCES, INC. (formerly Turbine Truck Engines, Inc.)

CONDENSED CONSOLIDATED BALANCE SHEETS

As of November 30, 2017 (unaudited) and August 31, 2017

 

  November 30, 2017   August 31, 2017 
   (unaudited)     
ASSETS        
Current Assets:          
Cash and cash equivalents  $1,295,632   $1,896,572 
Accounts receivable, net   1,288,959    1,128,898 
Other receivables   380,289    372,024 
Prepaid expenses and other current assets   192,033    252,536 
Total current assets   3,156,913    3,650,030 
           
Property and equipment, net   283,874    302,951 
Acquisition deposits   1,128,987    1,162,009 
Goodwill   388,050    399,400 
TOTAL ASSETS  $4,957,824   $5,514,390 
           
LIABILITIES AND STOCKHOLDERS' DEFICIT          
           
Current Liabilities:          
Accounts payable  $1,574,656   $1,703,342 
Accrued expenses   360,579    341,657 
Accrued interest (principally to related parties)   437,509    403,119 
Due to related parties   1,589,001    1,812,613 
Notes payable, current portion   6,073    13,171 
Total current liabilities   3,967,818    4,273,902 
           
Debentures, related parties   4,968,990    5,114,327 
Notes payable, net of current portion   402,368    414,351 
TOTAL LIABILITIES   9,339,176    9,802,580 
           
Commitments and contingencies (Note 9)   -    - 
           
STOCKHOLDERS' DEFICIT          
Novo Integrated Sciences, Inc.          
Convertible Preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at November 30, 2017 and August 31, 2017          
Common stock; $0.001par value; 499,000,000 shares authorized; 201,837,254 and 201,837,254 shares issued and outstanding at November 30, 2017 and August 31, 2017   201,837    201,837 
Additional paid-in capital   3,524,308    3,381,643 
Other comprehensive income   1,365,031    1,240,844 
Accumulated deficit   (9,449,265)   (9,091,977)
Total Novo Integrated Sciences, Inc. stockholders' deficit   (4,358,089)   (4,267,653)
Noncontrolling interest   (23,263)   (20,537)
Total stockholders' deficit   (4,381,352)   (4,288,190)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT  $4,957,824   $5,514,390 

 

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

 

2

 

 

NOVO INTEGRATED SCIENCES, INC. (formerly Turbine Truck Engines, Inc.)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

For the Three Months Ended November 30, 2017 and 2016 (unaudited)

 

  

Three Months Ended

 
   November 30, 2017   November 30, 2016 
   (unaudited)   (unaudited) 
         
Revenues  $2,253,737   $1,818,139 
           
Cost of revenues   1,407,693    1,164,113 
           
Gross profit   846,044    654,026 
           
Operating expenses:          
Selling expenses   38,139    10,301 
General and administrative expenses   980,275    580,864 
Total operating expenses   1,018,414    591,165 
           
Income (loss) from operations   (172,370)   62,861 
           
Non operating income (expense)          
Interest income   51    10,978 
Interest expense   (134,153)   (117,088)
Total other income (expense)   (134,102)   (106,110)
           
Loss before income taxes   (306,472)   (43,249)
           
Income tax expense   54,216    - 
           
Net loss  $(360,688)  $(43,249)
           
Net loss attributed to noncontrolling interest   (3,400)   (1,727)
           
Net loss attributed to Novo Integrated Sciences, Inc.  $(357,288)  $(41,522)
           
Comprehensive income (loss):          
Net loss   (360,688)   (43,249)
Foreign currency translation gain   124,187    161,143 
Comprehensive income (loss):  $(236,501)  $117,894 
           
Weighted average common shares outstanding - basic and diluted   201,837,254    167,797,406 
           
Net loss per common share - basic and diluted  $(0.00)  $(0.00)

 

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

 

3

 

 

NOVO INTEGRATED SCIENCES, INC. (formerly Turbine Truck Engines, Inc.)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Three Months Ended November 30, 2017 and 2016 (unaudited)

 

   Three Months Ended 
   November 30, 2017   November 30, 2016 
   (unaudited)   (unaudited) 
         
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(360,688)  $(43,249)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation   14,998    15,580 
Fair value of vested stock options   142,665    - 
Changes in operating assets and liabilities:          
Accounts receivable   (197,389)   (47,705)
Prepaid expenses and other current assets   54,786    20,459 
Accounts payable   (82,701)   (19,698)
Accrued expenses   29,415    25,934 
Accrued interest   47,099    83,132 
Net cash provided by (used in) operating activities   (351,815)   34,453 
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of furniture and equipment   (4,242)   (14,149)
Amounts loaned for other receivables   (19,351)   - 
Repayments of other receivables   -    376,850 
Net cash provided by (used in) investing activities   (23,593)   362,701 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Repayments from related parties   (176,804)   (192,388)
Payments on notes payable   (7,121)   (10,097)
Net cash used in financing activities   (183,925)   (202,485)
           
Effect of exchange rate changes on cash and equivalents   (41,607)   (4,829)
           
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS   (600,940)   189,840 
           
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD   1,896,572    110,315 
           
CASH AND CASH EQUIVALENTS, END OF PERIOD  $1,295,632   $300,155 
           
CASH PAID FOR:          
Interest  $99,763   $53,855 
Income taxes  $-   $- 

 

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Three Months Ended November 30, 2017 and 2016 (unaudited)

 

Note 1 - Organization and Basis of Presentation

 

Organization and Line of Business

 

Novo Integrated Sciences, Inc. was incorporated in Delaware on November 27, 2000, under the name Turbine Truck Engines, Inc. On February 20, 2008, the Company was re-domiciled to the State of Nevada. Effective July 12, 2017, the Company’s name was changed to Novo Integrated Sciences, Inc. When used herein, the terms the “Company,” “we,” “us” and “our” refer to Novo Integrated Sciences, Inc. and its consolidated subsidiaries.

 

We provide specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology and dental services to our clients. Our multi-disciplinary primary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation and prevention through our 14 corporate owned clinics, 150 affiliate clinics, retirement homes, long-term care facilities and institutional locations throughout Canada. Directly and indirectly through our contractual relationships, we provide our specialized services to over 300,000 patients annually. No employee of the Company or any of its subsidiaries practices primary care medicine and the Company’s services do not require a medical or nursing license.

 

On April 25, 2017 (the “Effective Date”), the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) by and between (i) the Company; (ii) NHL, (iii) ALMC-ASAP Holdings Inc. (“ALMC”); (iv) Michael Gaynor Family Trust (the “MGFT”); (v) 1218814 Ontario Inc. (“1218814”) and (vi) Michael Gaynor Physiotherapy Professional Corp. (“MGPP,” and together with ALMC, MGFT and 1218814, the “NHL Shareholders”). Pursuant to the terms of the Share Exchange Agreement, the Company agreed to acquire from the NHL Shareholders all of the shares of both common and preferred stock of NHL, held by the NHL Shareholders, in exchange for the issuance by the Company to the NHL Shareholders of shares of the Company’s common stock, such that following the closing of the Share Exchange Agreement, the NHL Shareholders would own 167,797,406 restricted shares of Company common stock, representing 85% of the issued and outstanding Company common stock, calculated including all granted and issued options or warrants to acquire the Company common stock as of the Effective Date, but to exclude shares of Company common stock that are subject to a then-current Regulation S offering that was undertaking by the Company (the “Exchange”).

 

On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.

 

The Exchange was accounted for as a reverse acquisition under the purchase method of accounting since NHL obtained control of Novo Integrated Sciences, Inc. Accordingly, the Exchange was recorded as a recapitalization of NHL, with NHL being treated as the continuing entity. The historical financial statements presented are the financial statements of NHL. The Share Exchange Agreement was treated as a recapitalization and not as a business combination; therefore, no pro forma information is disclosed. At the closing date of the Exchange, the net assets of the legal acquirer, Novo Integrated Sciences, Inc., were $6,904.

 

On May 9, 2017, our Board of Directors determined, in connection with the closing of the Exchange, to change our fiscal year end from December 31 to August 31, but did not memorialize such determination in writing. On July 17, 2017, the Board ratified and memorialized in writing its May 9, 2017 determination regarding the change in fiscal year end.

 

The unaudited consolidated financial statements are prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The information furnished herein reflects all adjustments, consisting only of normal recurring adjustments, which in the opinion of management, are necessary to fairly state the Company’s financial position, the results of its operations, and cash flows for the periods presented. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) were omitted pursuant to such rules and regulations. The results of operations for the three months ended November 30, 2017 are not necessarily indicative of the results for the year ending August 31, 2018.

 

5

 

 

Basis of Presentation

 

The accompanying consolidated financial statements were prepared in conformity with U.S. GAAP. The Company’s Canadian subsidiaries’ functional currency is the Canadian Dollar (“CAD”); however, the accompanying consolidated financial statements were translated and presented in United States Dollars (“$” or “USD”).

 

Foreign Currency Translation

 

The accounts of the Company’s Canadian subsidiaries are maintained in CAD. The accounts of these subsidiaries are translated into USD in accordance with ASC Topic 830 Foreign Currency Transaction, with the CAD as the functional currency. According to Topic 830, all assets and liabilities are translated at the exchange rate on the balance sheet date, stockholders’ equity is translated at historical rates and statement of operations items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, Comprehensive Income. Gains and losses resulting from the translations of foreign currency transactions and balances are reflected in the statement of operations and comprehensive income. The following table details the exchange rates used for the respective periods:

 

   November 30, 2017   November 30, 2016   August 31, 2017 
             
Period end: CAD to USD exchange rate  $0.7761   $0.7447   $0.7988 
Average period: CAD to USD exchange rate  $0.7973   $0.7537      

 

Note 2 – Summary of Significant Accounting Policies

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, NHL, Novo Peak Health Inc., Novo Healthnet Rehab Limited, Novo Assessments Inc., an 80% interest in Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, and a fifty percent stake in a joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated as Novo Dental. All of the Company’s subsidiaries are incorporated under the laws of the Province of Ontario, Canada. All intercompany transactions have been eliminated.

 

Noncontrolling Interest

 

The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, which governs the accounting for and reporting of non-controlling interests (“NCIs”) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent’s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.

 

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

 

6

 

 

Cash Equivalents

 

For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less.

 

Accounts Receivable

 

Accounts receivable are recorded, net of allowance for doubtful accounts and sales returns. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentration, customer credit worthiness, current economic trends and changes in customer payment patterns to determine if the allowance for doubtful accounts is adequate. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Delinquent account balances are written-off after management has determined that the likelihood of collection is not probable and known bad debts are written off against the allowance for doubtful accounts when identified. As of November 30, 2017 and August 31, 2017, the allowance for uncollectible accounts receivable was $474,376 and $507,636, respectively.

 

Property and Equipment

 

Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:

 

Leasehold improvements 5 years
Clinical equipment 5 years
Computer equipment 3 years
Office equipment 5 years
Furniture and fixtures 5 years

 

Long-Lived Assets

 

The Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at November 30, 2017 and August 31, 2017, the Company believes there was no impairment of its long-lived assets.

 

Goodwill

 

Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. Under accounting requirements, goodwill is not amortized but is subject to annual impairment tests. The Company recorded goodwill of $388,050 at November 30, 2017 related to its acquisition of Apka Health, Inc. during fiscal year ended August 31, 2017. As of August 31, 2017, the Company performed the required impairment review. Based on its review at August 31, 2017, the Company believes there was no impairment of its goodwill.

 

7

 

 

Acquisition Deposits

 

The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,128,987 at November 30, 2017.

 

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash and equivalents, restricted cash, accounts receivable, advances to suppliers, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.

 

FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the fair value of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

  Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.
     
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
     
  Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the fair value measurement.

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.

 

As of November 30, 2017 and August 31, 2017, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.

 

Revenue Recognition

 

Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with FASB ASC 605, Revenue Recognition: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

 

Income Taxes

 

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

8

 

 

Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.

 

Stock-Based Compensation

 

The Company records stock-based compensation in accordance with FASB ASC Topic 718, Compensation – Stock Compensation. FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at fair value at the grant date and recognize the expense over the requisite service period. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees.

 

Basic and Diluted Earnings Per Share

 

Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. There were 7,980,000 options/warrants outstanding as of November 30, 2017. Due to the net loss incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented.

 

Foreign Currency Transactions and Comprehensive Income

 

U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian $. Translation gains of $1,365,031 and $1,240,844 at November 30, 2017 and August 31, 2017, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

 

Statement of Cash Flows

 

Cash flows from the Company’s operations are calculated based upon the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.

 

Recent Accounting Pronouncements

 

In January 2017, the FASB issued an Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.

 

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

9

 

 

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company’s financial statements and disclosures.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 

Note 3 – Related Party Transactions

 

Due to related parties

 

Amounts loaned to the Company by stockholders and officers of the Company that are non-interest bearing and payable upon demand.

 

10

 

 

Note 4 – Other Receivables

 

Other receivables at November 30, 2017 and August 31, 2017 consisted of the following:

 

   November 30, 2017   August 31, 2017 
Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; due November 15, 2016.  $-   $39,940 
Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 12% per annum; secured by certain assets; due May 23, 2018.   291,037    299,550 
Advance to corporation; non-interest bearing; unsecured; payable upon demand   31,044    32,534 
Advance to corporation; non-interest bearing; unsecured; payable upon demand   58,208    - 
Total other receivables  $380,289   $372,024 

 

Note 5 – Property and Equipment

 

Property and equipment at November 30, 2017 and August 31, 2017 consisted of the following:

 

   November 30, 2017   August 31, 2017 
Leasehold Improvements  $320,607   $329,985 
Clinical equipment   167,524    177,514 
Computer equipment   21,345    21,020 
Office equipment   23,628    24,319 
Furniture and fixtures   25,854    18,218 
    558,958    571,056 
Accumulated depreciation   (275,084)   (268,105)
Total  $283,874   $302,951 

 

Depreciation expense for the three months ended November 30, 2017 and 2016 was $14,998 and $15,580, respectively.

 

Note 6 – Notes Payable

 

Notes payable at November 30, 2017 and August 31, 2017 consisted of the following:

 

   November 30, 2017   August 31, 2017 
Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017. This note has been fully repaid.   -    7,134 
Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 21, 2019.   388,050    399,400 
Notes payable assumed with acquisition; accrues interest at 6% per annum; monthly principal and interest payment of $619; unsecured; due April 8, 2019.   20,391    20,988 
    408,441    427,522 
Current portion   (6,073)   (13,171)
Long-term portion  $402,368   $414,351 

 

Aggregate future maturities of notes payable as of November 30 are as follows:

 

Twelve months ending November 30,    
2018  $6,073 
2019   402,368 
   $408,441 

 

Note 7 – Debentures, related parties

 

On September 30, 2013, the Company issued five debentures totaling $4,968,990 (CAD$6,402,512) at November 30, 2017 in connection with the acquisition of certain business assets. The holders of the debentures are current stockholders, officers and/or affiliates of the Company. The debentures are secured by all the assets of the Company, accrue interest at 8% per annum and were originally due on September 30, 2016. On December 2, 2017, the debenture holders agreed to extend the due date to September 30, 2019. On December 5, 2017, the debenture holders and the Company signed a binding Letter of Intent to convert no less than seventy-five percent (75%) of the debenture value plus any interest or fees owed to the Company’s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.

 

Note 8 – Stockholders’ Deficit

 

Convertible preferred stock

 

The Company has authorized 1,000,000 shares of $0.001 par value convertible preferred stock. At November 30, 2017 and August 31, 2017 there were 0 and 0 convertible preferred shares issued and outstanding, respectively.

 

Common stock

 

The Company has authorized 499,000,000 shares of $0.001 par value common stock. At November 30, 2017 and August 31, 2017 there were 201,837,254 and 201,837,254 common shares issued and outstanding, respectively.

 

Stock options/warrants

 

On September 8, 2015, the Company adopted the 2015 Incentive Compensation Plan (the “2015 Plan”), which authorizes the issuance of up to 5,000,000 shares of common stock to employees, officers, directors or independent consultants of the Company, provided that no person can be granted shares under the 2015 Plan for services related to raising capital or promotional activities. During 2017 and 2016, the Company did not grant any awards under the 2015 Plan. As of August 31, 2017, 4,987,500 shares were available under the 2015 Plan for future grants, awards, options or share issuances. However, because the shares issuable under the 2015 Plan or issuable upon conversion of awards granted under the Plan are no longer registered under the Securities Exchange Act of 1934, as amended, the Company does not intend to issue any additional grants under the 2015 Plan.

 

11

 

 

The following is a summary of stock option/warrant activity:

 

           Weighted     
       Weighted   Average     
   Options/   Average   Remaining   Aggregate 
   Warrants   Exercise   Contractual   Intrinsic 
   Outstanding   Price   Life   Value 
Outstanding, August 31, 2017   7,860,000   $0.266    3.53   $660,000 
Granted   120,000    0.400           
Forfeited   -                
Exercised   -                
Outstanding, November 30, 2017   7,980,000    0.268    3.56    1,797,200 
Exercisable, November 30, 2017   6,920,000   $0.259    3.36   $1,653,600 

 

The exercise price for options/warrants outstanding at November 30, 2017:

 

Outstanding   Exercisable 
Number of       Number of     
Options/   Exercise   Options/   Exercise 
Warrants   Price   Warrants   Price 
 5,500,000   $0.16    5,500,000   $0.16 
 1,000,000    0.32    -    0.32 
 120,000    0.40    60,000    0.40 
 100,000    0.50    100,000    0.50 
 1,000,000    0.62    1,000,000    0.62 
 250,000    0.80    250,000    0.80 
 10,000    2.00    10,000    2.00 
 7,980,000         6,920,000      

 

For options granted during fiscal year 2017 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.58 and the weighted-average exercise price of such options/warrants was $0.42. No options were granted during fiscal 2017 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.

 

For options granted during fiscal year 2018 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.39 and the weighted-average exercise price of such options/warrants was $0.40. No options were granted during fiscal 2018 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.

 

The fair value of the stock options is being amortized to stock option expense over the vesting period. The Company recorded stock option expense of $142,665 during the three months ended November 30, 2017. At November 30, 2017, the unamortized stock option expense was $286,413.

 

The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:

 

Risk-free interest rate   1.5%
Expected life of the options   2.5 years 
Expected volatility   323%
Expected dividend yield   0%

 

12

 

 

Note 9 – Commitments and Contingencies

 

Litigation

 

The Company is party to certain legal proceedings from time to time incidental to the conduct of its business. These proceedings could result in fines, penalties, compensatory or treble damages or non-monetary relief. The nature of legal proceedings is such that the Company cannot assure the outcome of any particular matter, and an unfavorable ruling or development could have a materially adverse effect on our consolidated financial position, results of operations and cash flows in the period in which a ruling or settlement occurs. However, based on information available to the Company’s management to date, the Company’s management does not expect that the outcome of any matter pending against the Company is likely to have a materially adverse effect on the Company’s consolidated financial position as of November 30, 2017, results of operations, cash flows or liquidity of the Company.

 

Leases

 

The Company leases its office space and certain facilities under long-term operating leases expiring through fiscal year 2023. Rent expense under these leases was $191,940 and $193,501 for the three months ended November 30, 2017 and 2016, respectively.

 

Note 10 – Subsequent Events

 

On December 1, 2017, the Company and Executive Fitness Leaders, located in Ottawa Ontario Canada, entered into an Asset Purchase Agreement, pursuant to which the Company acquired substantially all of the assets of Executive Fitness Leaders in exchange for the issuance, by the Company, of 384,110 restricted shares of its common stock valued at approximately $233,155. The transaction closed on December 1, 2017. The purchase of these assets was not considered significant for accounting purposes; therefore, pro forma financial statements are not presented.

 

On December 2, 2017, the Company and certain related party debenture holders of five debentures totaling $4,968,990 (CAD$6,402,512) dated September 30, 2013 with an original due date of September 30, 2016 (see Note 7 for further details) agreed to extend the due date of the debentures to September 30, 2019.

 

On December 5, 2017, the related party debenture holders and the Company signed a binding Letter of Intent to convert no less than 75% of the debenture value, plus any interest or fees owed, to the Company’s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five trading days immediately preceding the date of conversion with a 10% premium added to the calculated per share price.

 

On December 26, 2017, the Company entered into a binding letter of intent (the “LOI”) with Brands International Corporation (“Brands”), pursuant to which the Company agreed to acquire 60% of the issued and outstanding shares of Brands in exchange for the arrangement of secured debt financing in the amount of CAD$2,350,000 (approximately $1,873,256 per the Bank of Canada posted exchange rate of 0.7977 on December 29, 2017) arranged or provided by the Company (the “Acquisition”). Upon completion of the Acquisition, the Company will own 60% of Brands’ issued and outstanding shares and Brands will be a partially-owned subsidiary of the Company. In connection with the Acquisition, the Company will enter into a shareholder agreement with Mark Rubinoff and a management agreement with Mark Rubinoff and DJ Robinoff. In addition, pursuant to the terms of the LOI, the Company agreed to provide Mark Rubinoff with a buyout structure for the remaining 40% of Brands’ shares with a trigger date of 24 months from the closing of the Acquisition.

 

The parties to the LOI agreed to proceed reasonably and in good faith toward negotiation and execution of a definitive acquisition agreement (a “Definitive Agreement”), and to use their commercially reasonable best efforts to obtain necessary board, stockholder and regulatory approvals and third party consents.

 

13

 

 

The parties to the LOI also agreed that from the date of the LOI until the earlier of January 30, 2018 (the “Termination Date”) and the date the parties enter into a Definitive Agreement, the parties and their respective directors, officers, agents and representatives will not:

 

  solicit, initiate or encourage the initiation of any expression of interest, inquiries or proposals regarding, constituting or that may reasonably be expected to lead to any merger, amalgamation, takeover bid, tender offer, arrangement, recapitalization, liquidations, dissolution, share exchange, sale of material assets involving the parties or a proposal or offer to do so (the “Acquisition Proposal”) (including without limitation, any grant of an option or other right to take any such action);
     
  participate in any discussions or negotiations regarding an Acquisition Proposal;
     
  accept or enter into, or propose publicly to accept or enter into, any agreement, letter of intent, memorandum of understanding or any arrangement in respect of an Acquisition Proposal; and
     
  otherwise cooperate in any way, assist or participate in, facilitate or encourage any effort or attempt by any person to do any of the foregoing.

 

In addition, Brands agreed not to solicit funds in any secured or unsecured debt form resulting in a change in the company’s financials unless the Company is made aware of such solicitation in writing.

 

If the Definitive Agreement is not negotiated and executed by both parties on or before the Termination Date, or such other date as agreed to by the parties in writing, the terms of the LOI will be of no further force or effect except for the confidentiality, costs and governing laws provisions, which sections will remain in effect for a period of one year following the date on which the LOI is terminated.

 

On December 29, 2017, the Company entered into an employment agreement (the “Employment Agreement”) with Christopher David, the Company’s President and a member of the board of directors, effective January 1, 2018. The Employment Agreement terminates on July 30, 2018, subject to the termination provisions contained in the Employment Agreement.

 

Pursuant to the terms of the Employment Agreement, Mr. David agreed to serve as the Company’s President. In consideration thereof, the Company agreed to (i) pay Mr. David a monthly salary of $8,000, and (ii) grant Mr. David a 5-year option (the “Option”) to purchase 2,000,000 shares of the Company’s restricted common stock at an exercise price of $0.42 per share. The Option vested on December 29, 2017.

 

Pursuant to the terms of the Employment Agreement, the Company may terminate Mr. David at any time, with or without Cause (as defined below); provided, however, that if the Company terminates Mr. David without Cause:

 

(a) The Option shall be deemed fully vested effective as of December 29, 2017, and is not subject to revocation or return, and

 

(b) The Company will continue to owe Mr. David his monthly salary through July 30, 2018.

 

“Cause” means Mr. David must have (i) been willful, gross or persistent in his inattention to his duties or he committed acts which constitute willful or gross misconduct and, after written notice of the same, has been given the opportunity to cure the same within 30 days after such notice, and (ii) been found guilty of having committed a fraud against the Company.

 

On December 29, 2017, the Company granted the Option to Mr. David pursuant to that certain Option to Purchase Common Stock (the “Option Agreement”). The Option Agreement provides for the cashless exercise of all or a portion of the Option, or exercise through payment of the exercise price in cash.

 

14

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The Private Securities Litigation Reform Act of 1995 and Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), provide a safe harbor for forward-looking statements made by or on behalf of the Company. The Company and its representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this report and other filings with the Securities and Exchange Commission (“SEC”) and in our reports and presentations to stockholders or potential stockholders. In some cases forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties can be found in the Part I, Item 1A, “Risk Factors” section of the Company’s Form 10-K for the fiscal year ended August 31, 2017.

 

Although we believe the expectations reflected in our forward-looking statements are based upon reasonable assumptions, it is not possible to foresee or identify all factors that could have a material effect on the future financial performance of the Company. The forward-looking statements in this report are made on the basis of management’s assumptions and analyses, as of the time the statements are made, in light of their experience and perception of historical conditions, expected future developments and other factors believed to be appropriate under the circumstances.

 

Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained in this Quarterly Report on Form 10-Q and the information incorporated by reference in this report to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based.

 

Overview of the Company

 

Novo Integrated Sciences, Inc. was incorporated in Delaware on November 27, 2000, under the name Turbine Truck Engines, Inc. On February 20, 2008, the Company was re-domiciled to the State of Nevada. Effective July 12, 2017, the Company’s name was changed to Novo Integrated Sciences, Inc. When used herein, the terms the “Company,” “we,” “us” and “our” refer to Novo Integrated Sciences, Inc. and its consolidated subsidiaries.

 

We provide specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology and dental services to our clients. Our multi-disciplinary primary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation and prevention through our 14 corporate owned clinics, 150 affiliate clinics, retirement homes, long-term care facilities and institutional locations throughout Canada. Directly and indirectly through our contractual relationships, we provide our specialized services to over 300,000 patients annually. No employee of the Company or any of its subsidiaries practices primary care medicine and the Company’s services do not require a medical or nursing license.

 

Our strict adherence to public regulatory standards, as well as self-imposed standards of excellence, have allowed us to navigate with ease through the industry’s licensing and regulatory framework. Compliant treatment, data and administrative protocols are managed through a team of highly-trained, certified healthcare and administrative professionals. Novo Healthnet Limited, our wholly owned subsidiary (“NHL”), and its direct and indirect subsidiaries are regulated under the Financial Services Commission of Ontario (“FSCO”). In 2013, NHL received its accreditation from the Commission on Accreditation of Rehabilitation Facilities (“CARF”). Currently, NHL is undergoing the CARF re-accreditation process.

 

15

 

 

Recent Developments

 

Share Exchange Agreement

 

On April 25, 2017 (the “Effective Date”), the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) by and between (i) the Company; (ii) NHL, (iii) ALMC-ASAP Holdings Inc. (“ALMC”); (iv) Michael Gaynor Family Trust (the “MGFT”); (v) 1218814 Ontario Inc. (“1218814”) and (vi) Michael Gaynor Physiotherapy Professional Corp. (“MGPP,” and together with ALMC, MGFT and 1218814, the “NHL Shareholders”). Pursuant to the terms of the Share Exchange Agreement, the Company agreed to acquire from the NHL Shareholders all of the shares of both common and preferred stock of NHL, held by the NHL Shareholders, in exchange for the issuance by the Company to the NHL Shareholders of shares of the Company’s common stock, such that following the closing of the Share Exchange Agreement, the NHL Shareholders would own 167,797,406 restricted shares of Company common stock, representing 85% of the issued and outstanding Company common stock, calculated including all granted and issued options or warrants to acquire the Company common stock as of the Effective Date, but to exclude shares of Company common stock that are subject to a then-current Regulation S offering that was undertaking by the Company (the “Exchange”).

 

On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.

 

Increase in Size of Board of Directors; Officer and Director Changes

 

In connection with the Exchange closing, our Board of Directors increased the size of the Board, such that the size of the Board is currently comprised of three members.

 

On May 9, 2017, in connection with the Exchange, (i) Enzo Cirillo resigned his positions as the Company’s Chairman of the Board, a member of the Board of Directors and Interim Chief Executive Officer, (ii) Christopher David resigned his position as the Company’s Secretary and Treasurer, and (iii) Judith Norstrud resigned her position as the Company’s Principal Financial Officer and Principal Accounting Officer. Mr. David retained his responsibilities as the Company’s President and as a member of the Company’s Board of Directors.

 

Also on May 9, 2017, the Board appointed Dr. Pierre Dalcourt, D.C. and Mr. Michael Gaynor as directors, and Ms. Klara Radulyne, CPA as the Company’s Principal Financial Officer, effective immediately. Mr. Gaynor is the trustee of MGFT. As a result of the Exchange, MGFT acquired 16,779,740 shares of the Company’s common stock, which represented approximately 8.5% of the Company’s outstanding common stock as of the date of the closing of the Exchange. As of the closing date of the Exchange, the value of MGFT’s stock ownership was $14,094,982, based on the closing price of the Company’s common stock of $0.84 on May 9, 2017. Dr. Dalcourt is the President and 50% owner of 1218814. Amanda Dalcourt, NHL’s Chief Executive Officer and Dr. Dalcourt’s spouse, also is a 50% owner of 1218814. As a result of the Exchange, 1218814 acquired 31,881,507 shares of the Company’s common stock, which represented approximately 16.2% of the Company’s outstanding common stock as of the date of the closing of the Exchange. As of the closing date of the Exchange, the value of 1218814’s stock ownership was $26,780,466, based on the closing price of the Company’s common stock of $0.84 on May 9, 2017. The value of each of Dr. Dalcourt’s and Ms. Dalcourt’s ownership interests in 1218814’s Company common stock as of May 9, 2017, based on the closing price of the Company’s common stock on May 9, 2017, was $13,390,233.

 

Acquisition of Executive Fitness Leaders

 

On December 1, 2017, the Company and Executive Fitness Leaders, located in Ottawa Ontario Canada, entered into an Asset Purchase Agreement, pursuant to which the Company acquired substantially all of the assets of Executive Fitness Leaders in exchange for the issuance, by the Company, of 384,110 restricted shares of its common stock valued at approximately $233,155. The transaction closed on December 1, 2017. The purchase of these assets was not considered significant for accounting purposes; therefore, pro forma financial statements are not presented.

 

Extension of Due Date of Debentures

 

On December 2, 2017, the Company and certain related party debenture holders of five debentures totaling $5,114,327 (CAD$6,402,512) dated September 30, 2013 with an original due date of September 30, 2016 (see financial note 7 for further details) agreed to extend the due date of the debentures to September 30, 2019.

 

16

 

 

Agreement to Convert Debentures

 

On December 5, 2017, the related party debenture holders and the Company signed a binding Letter of Intent to convert no less than 75% of the debenture value, plus any interest or fees owed, to the Company’s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five trading days immediately preceding the date of conversion with a 10% premium added to the calculated per share price.

 

Brands International Corporation Letter of Intent

 

On December 26, 2017, the Company entered into a binding letter of intent (the “LOI”) with Brands International Corporation (“Brands”), pursuant to which the Company agreed to acquire 60% of the issued and outstanding shares of Brands in exchange for the arrangement of secured debt financing in the amount of CAD$2,350,000 (approximately $1,873,256 per the Bank of Canada posted exchange rate of 0.7977 on December 29, 2017) arranged or provided by the Company (the “Acquisition”). Upon completion of the Acquisition, the Company will own 60% of Brands’ issued and outstanding shares and Brands will be a partially-owned subsidiary of the Company. In connection with the Acquisition, the Company will enter into a shareholder agreement with Mark Rubinoff and a management agreement with Mark Rubinoff and DJ Robinoff. In addition, pursuant to the terms of the LOI, the Company agreed to provide Mark Rubinoff with a buyout structure for the remaining 40% of Brands’ shares with a trigger date of 24 months from the closing of the Acquisition.

 

The parties to the LOI agreed to proceed reasonably and in good faith toward negotiation and execution of a definitive acquisition agreement (a “Definitive Agreement”), and to use their commercially reasonable best efforts to obtain necessary board, stockholder and regulatory approvals and third party consents.

 

The parties to the LOI also agreed that from the date of the LOI until the earlier of January 30, 2018 (the “Termination Date”) and the date the parties enter into a Definitive Agreement, the parties and their respective directors, officers, agents and representatives will not:

 

solicit, initiate or encourage the initiation of any expression of interest, inquiries or proposals regarding, constituting or that may reasonably be expected to lead to any merger, amalgamation, takeover bid, tender offer, arrangement, recapitalization, liquidations, dissolution, share exchange, sale of material assets involving the parties or a proposal or offer to do so (the “Acquisition Proposal”) (including without limitation, any grant of an option or other right to take any such action);
   
participate in any discussions or negotiations regarding an Acquisition Proposal;
   
accept or enter into, or propose publicly to accept or enter into, any agreement, letter of intent, memorandum of understanding or any arrangement in respect of an Acquisition Proposal; and
   
otherwise cooperate in any way, assist or participate in, facilitate or encourage any effort or attempt by any person to do any of the foregoing.

 

In addition, Brands agreed not to solicit funds in any secured or unsecured debt form resulting in a change in the company’s financials unless the Company is made aware of such solicitation in writing.

 

If the Definitive Agreement is not negotiated and executed by both parties on or before the Termination Date, or such other date as agreed to by the parties in writing, the terms of the LOI will be of no further force or effect except for the confidentiality, costs and governing laws provisions, which sections will remain in effect for a period of one year following the date on which the LOI is terminated.

 

17

 

 

David Employment Agreement & Option Grant

 

On December 29, 2017, the Company entered into an employment agreement (the “Employment Agreement”) with Christopher David, the Company’s President and a member of the board of directors, effective January 1, 2018. The Employment Agreement terminates on July 30, 2018, subject to the termination provisions contained in the Employment Agreement.

 

Pursuant to the terms of the Employment Agreement, Mr. David agreed to serve as the Company’s President. In consideration thereof, the Company agreed to (i) pay Mr. David a monthly salary of $8,000, and (ii) grant Mr. David a 5-year option (the “Option”) to purchase 2,000,000 shares of the Company’s restricted common stock at an exercise price of $0.42 per share. The Option vested on December 29, 2017.

 

Pursuant to the terms of the Employment Agreement, the Company may terminate Mr. David at any time, with or without Cause (as defined below); provided, however, that if the Company terminates Mr. David without Cause:

 

(a) The Option shall be deemed fully vested effective as of December 29, 2017, and is not subject to revocation or return, and

 

(b) The Company will continue to owe Mr. David his monthly salary through July 30, 2018.

 

“Cause” means Mr. David must have (i) been willful, gross or persistent in his inattention to his duties or he committed acts which constitute willful or gross misconduct and, after written notice of the same, has been given the opportunity to cure the same within 30 days after such notice, and (ii) been found guilty of having committed a fraud against the Company.

 

On December 29, 2017, the Company granted the Option to Mr. David pursuant to that certain Option to Purchase Common Stock (the “Option Agreement”). The Option Agreement provides for the cashless exercise of all or a portion of the Option, or exercise through payment of the exercise price in cash.

 

For the three months ended November 30, 2017 compared to the three months ended November 30, 2016

 

Revenues for the three months ended November 30, 2017 were $2,253,737, representing an increase of $435,598, or 24.0%, from $1,818,139 for the same period in 2016. The increase in revenue is principally due to the Company’s entry into new occupational therapy service contracts in January 2017 and the acquisition of Apka Health, Inc. in April 2017.

 

Cost of revenues for the three months ended November 30, 2017 were $1,407,693, representing an increase of $243,580, or 20.9%, from $1,164,113 for the same period in 2016. The increase in cost of revenues is principally due to the increase in revenues. Cost of revenues as a percentage of revenue was 62.5% for the three months ended November 30, 2017 and 64.0% for same period in 2016. The decrease in cost of revenues as a percentage of revenue is principally due to slightly lower costs.

 

Operating costs for the three months ended November 30, 2017 were $1,018,414, representing an increase of $427,249, or 72.3%, from $591,165 for the same period in 2016. The increase in operating costs is attributed to stock-based compensation of $142,665 for the three months ended November 30, 2017 (there was no stock-based compensation for the same period in 2016), as well as an increase in both operating payroll expenses and professional fees.

 

Interest expense for the three months ended November 30, 2017 was $134,153, representing an increase of $17,065, or 14.6%, from $117,088 for the same period in 2016. The increase is due to interest during the three months ended November 30, 2017 related to payroll withholdings originating in fiscal years 2014 and 2015.

 

Net loss for the three months ended November 30, 2017 was $360,688, representing an increase of $317,439, or 734.0%, from $43,249 for the same period in 2016. The increase in net loss is due to the reasons described above.

 

18

 

 

Liquidity and Capital Resources

 

As shown in the accompanying financial statements, for the three months ended November 30, 2017, the Company had a net loss of $360,688.

 

During the three months ended November 30, 2017, the Company used cash in operating activities of $351,815 compared to generating cash from operations of $34,453 for the same period in 2016. The principal reason for the decrease is the additional net loss incurred during the three months ended November 30, 2017 as compared to the same period in 2016 and a larger increase in accounts receivable during the three months ended November 30, 2017 compared to the same period in 2016.

 

During the three months ended November 30, 2017, the Company used cash in investing activities of $23,593 compared to cash provided by investing activities of $362,701 for the same period in 2016. The principal reason for the change is the repayment of other receivables during the three months ended November 30, 2016.

 

During the three months ended November 30, 2017, the Company used cash of $183,925 from financing activities compared to $202,485 for the same period in 2016. The principal reason for the decrease is due to repayments of amounts due to related parties.

 

On March 8, 2017, the Company sold 33,333 restricted shares of common stock to 2367416 Ontario, Inc. The shares were sold at a price of $0.45 per share, for an aggregate purchase price of $15,000. This sale of 33,333 restricted shares occurred prior to the share exchange as described above. The $15,000 was provided to fund the Company’s ongoing operational and product development expenses. At the time of the sale, Enzo Cirillo was the Company’s Interim CEO, Chairman of the Board and a greater than 10% shareholder of the Company’s common stock, as well as the principal partner of 2367416 Ontario, Inc. Effective May 9, 2017, Mr. Cirillo resigned as an officer and director of the Company. Additionally, with the closing of the Share Exchange Agreement between the Company and Novo Healthnet Limited, Mr. Cirillo is no longer a greater than 10% shareholder of the Company’s common stock.

 

On May 19, 2017, the Company sold 8,368,500 restricted shares of common stock to an aggregate of 23 accredited investors. The shares were sold at a price of $0.30 per share, for an aggregate purchase price of $2,510,550. The $2,510,550 was provided to fund the Company’s ongoing operational and product development expenses. The shares were issued in reliance upon the exemptions provided by Regulation S promulgated pursuant to the Securities Act of 1933, as amended (the “Securities Act”). The issuances involved offers and sales of securities outside the United States. The offers and sales were made in offshore transactions and no directed selling efforts were made by the issuer, a distributor, their affiliates or any persons acting on their behalf.

 

On June 20, 2017, the Company sold 2,140,839 restricted shares of common stock to an aggregate of 12 accredited investors. The shares were sold at a price of $0.30 per share, for an aggregate purchase price of $642,250. The $642,250 was provided to fund the Company’s ongoing operational and product development expenses. The shares were issued in reliance upon the exemptions provided by Regulation S promulgated pursuant to the Securities Act. The issuances involved offers and sales of securities outside the United States. The offers and sales were made in offshore transactions and no directed selling efforts were made by the issuer, a distributor, their affiliates or any persons acting on their behalf.

 

On August 24, 2017, the Company sold 779,202 restricted shares of common stock to an aggregate of three accredited investors. The shares were sold at a price of $0.30 per share, for an aggregate purchase price of $233,760. The $233,760 was provided to fund the Company’s ongoing operational and product development expenses. The shares were issued in reliance upon the exemptions provided by Regulation S promulgated pursuant to the Securities Act. The issuances involved offers and sales of securities outside the United States. The offers and sales were made in offshore transactions and no directed selling efforts were made by the issuer, a distributor, their affiliates or any persons acting on their behalf.

 

19

 

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

We believe that the following critical policies affect our more significant judgments and estimates used in preparation of our financial statements.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

 

Noncontrolling Interest

 

The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, which governs the accounting for and reporting of non-controlling interests (“NCIs”) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent’s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.

 

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

 

Revenue Recognition

 

Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with FASB ASC 605, Revenue Recognition: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

 

20

 

 

Stock-Based Compensation

 

The Company records stock-based compensation in accordance with FASB ASC Topic 718, Compensation – Stock Compensation. FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at fair value at the grant date and recognize the expense over the requisite service period. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees.

 

Basic and Diluted Earnings Per Share

 

Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period.

 

Foreign Currency Transactions and Comprehensive Income

 

U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian $. Translation gains (losses) are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

 

New Accounting Pronouncements

 

In January 2017, the FASB issued an Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.

 

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.

 

21

 

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company’s financial statements and disclosures.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 

Recent accounting pronouncements issued by the FASB, the AICPA and the Securities and Exchange Commission did not or are not believed by management to have a material effect on the Company’s financial statements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

The Company’s President and Principal Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of November 30, 2017. Based upon such evaluation, the Company’s President and Principal Financial Officer have concluded that, as of November 30, 2017, the Company’s disclosure controls and procedures were not effective. The Company’s disclosure controls and procedures were determined to be ineffective due to the lack of segregation of duties. Currently, management contracts with an outside certified public accountant to assist the Company with preparation of its filings required pursuant to the Exchange Act.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 of the Exchange Act that occurred during the fiscal quarter ended November 30, 2017 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

Except as set forth herein, as of the date of this Quarterly Report on Form 10-Q, there are no material pending legal proceedings, other than ordinary routine litigation incidental to our business, to which we are a party or which our property is the subject. In addition, none of our officers, directors, affiliates or 5% stockholders (or any associates thereof) is a party adverse to us, or has a material interest adverse to us, in any material proceeding.

 

22

 

 

The Company is currently involved in litigation in Taiwan, wherein the Company engaged Formosan Brothers, a Taiwan-based law firm, to file a criminal complaint with the Taipei, Taiwan District Prosecutors Office (the “Prosecutor”) seeking criminal charges against the principal partners of ETS, Mr. Chen, Chong-Ping (“Alan Chen”) and Huang, Ren-Ju (“Mr. Huang”) for fraud in connection with their actions related to the Company’s business initiative to commercialize the HPBS technology in Asia.

 

On December 25, 2015, the Company received a written ruling from the Taiwan District Prosecutor’s Office that it had declined to prosecute Alan Chen and Mr. Huang for criminal fraud.

 

On January 4, 2016, the Company filed an appeal to the Taiwan High Prosecution Office. On February 1, 2016, the Company’s appeal was granted and the case was returned to the Taiwan District Court Prosecutor with instructions to conduct a new investigation of the facts and evidence. The Company intends to continue to pursue this matter until a final resolution is obtained.

 

On June 12, 2017, Mr. Chen was indicted and charged with criminal fraud and the Company was informed that Mr. Huang will not be indicted.

 

On the recommendation of both the Company’s Taiwan attorneys and the judge overseeing the criminal fraud case against Mr. Chen, the Company filed an ancillary civil action against Mr. Chen allowing the judge overseeing the criminal fraud case to initiate a mediation proceeding between the Company and Mr. Chen for a potential financial settlement. Mr. Chen did not appear for an August 1, 2017 mediation hearing but did appear for the subsequent criminal hearing. The defendant pleaded not guilty and the judge notified both parties the case will proceed to trial.

 

In late August 2017, the Company filed a Confiscation Application with the Taiwan Taipei District Court requesting the prosecutor’s office search for and confiscate any assets the prosecutor can locate in the name of Alan Chen as security for the compensation to the Company pending the criminal trial’s outcome. As of the date of this filing, the Company is awaiting the results of this Confiscation Application.

 

On November 23, 2017, Mr. Chen and the Company’s legal team appeared for a hearing to determine accepted facts and any additional evidence. The parties are waiting for the next court date to be scheduled.

 

ITEM 1A. RISK FACTORS

 

Not required for smaller reporting companies.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

There have been no defaults in any material payments during the covered period.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

(a) None.

 

(b) There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors since the Company last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K.

 

23

 

 

ITEM 6. EXHIBITS

 

Exhibit
Number
  Description of Document
     
31.1   Rule 13a-14(a) Certification of Principal Executive Officer
     
31.2   Rule 13a-14(a) Certification of Principal Financial Officer
     
32.1   Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of Principal Executive Officer and Principal Financial Officer
     
101.INS   XBRL Instance Document
     
101.SCH   XBRL Taxonomy Extension Schema Document
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase
     
101.LAB   XBRL Taxonomy Extension Labels Linkbase
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase

 

24

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereto duly authorized:

 

  NOVO INTEGRATED SCIENCES, INC.
     
Dated: January 12, 2018 By: /s/ Klara Radulyne
    Klara Radulyne
    Principal Financial Officer

 

25

 

EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATIONS

 

I, Christopher David, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended November 30, 2017 of Novo Integrated Sciences, Inc.; and
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; and
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 12, 2018 By: /s/ Christopher David
    Christopher David
    President (principal executive officer)

 

 

 

 

EX-31.2 3 ex31-2.htm

 

EXHIBIT 31.2

 

CERTIFICATIONS

 

I, Klara Radulyne, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended November 30, 2017 of Novo Integrated Sciences, Inc.; and
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; and
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 12, 2018 By: /s/ Klara Radulyne
    Klara Radulyne
    Principal Financial Officer

 

 

 

 

EX-32.1 4 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Novo Integrated Sciences, Inc. (the “Company”) on Form 10-Q for the quarter ended November 30, 2017 as filed with the Securities and Exchange Commission (the “Report”), I, Christopher David, President of the Company, and I, Klara Radulyne, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: January 12, 2018 /s/ Christopher David
 

Christopher David, President

(principal executive officer)

   
  /s/ Klara Radulyne
 

Klara Radulyne, Principal Financial Officer

(principal financial officer)

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

 

 

EX-101.INS 5 nvos-20171130.xml XBRL INSTANCE FILE 0001138978 2017-09-01 2017-11-30 0001138978 2018-01-09 0001138978 2017-08-31 0001138978 2017-11-30 0001138978 NVOS:TurbineTruckEnginesIncMember 2017-09-01 2017-11-30 0001138978 NVOS:TurbineTruckEnginesIncOneMember 2017-09-01 2017-11-30 0001138978 NVOS:ShareExchangeAgreementMember NVOS:NHLMember 2017-04-23 2017-04-25 0001138978 NVOS:PeriodEndMember NVOS:CADMember 2017-08-31 0001138978 NVOS:NovoHealthnetKemptvilleCentreIncMember 2017-11-30 0001138978 2016-09-01 2016-11-30 0001138978 us-gaap:LeaseholdImprovementsMember 2017-09-01 2017-11-30 0001138978 NVOS:ClinicalEquipmentMember 2017-09-01 2017-11-30 0001138978 us-gaap:ComputerEquipmentMember 2017-09-01 2017-11-30 0001138978 us-gaap:OfficeEquipmentMember 2017-09-01 2017-11-30 0001138978 us-gaap:FurnitureAndFixturesMember 2017-09-01 2017-11-30 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2017-08-31 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenandMayTwentyThreeTwoThousandSeventeenMember 2017-08-31 0001138978 NVOS:AdvanceToCorporationOneMember 2017-08-31 0001138978 NVOS:AdvanceToCorporationTwoMember 2017-08-31 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2016-09-01 2017-08-31 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2017-09-01 2017-11-30 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenandMayTwentyThreeTwoThousandSeventeenMember 2016-09-01 2017-08-31 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenandMayTwentyThreeTwoThousandSeventeenMember 2017-09-01 2017-11-30 0001138978 us-gaap:LeaseholdImprovementsMember 2017-08-31 0001138978 NVOS:ClinicalEquipmentMember 2017-08-31 0001138978 us-gaap:ComputerEquipmentMember 2017-08-31 0001138978 us-gaap:OfficeEquipmentMember 2017-08-31 0001138978 us-gaap:FurnitureAndFixturesMember 2017-08-31 0001138978 us-gaap:LeaseholdImprovementsMember 2017-11-30 0001138978 NVOS:ClinicalEquipmentMember 2017-11-30 0001138978 us-gaap:ComputerEquipmentMember 2017-11-30 0001138978 us-gaap:OfficeEquipmentMember 2017-11-30 0001138978 us-gaap:FurnitureAndFixturesMember 2017-11-30 0001138978 NVOS:NotePayableOneMember 2017-08-31 0001138978 NVOS:NotePayableTwoMember 2017-08-31 0001138978 NVOS:NotePayableThreeMember 2017-08-31 0001138978 NVOS:NotePayableOneMember 2017-11-30 0001138978 NVOS:NotePayableTwoMember 2017-11-30 0001138978 NVOS:NotePayableThreeMember 2017-11-30 0001138978 NVOS:NotePayableOneMember 2016-09-01 2017-08-31 0001138978 NVOS:NotePayableTwoMember 2016-09-01 2017-08-31 0001138978 NVOS:NotePayableThreeMember 2016-09-01 2017-08-31 0001138978 NVOS:ExercisePriceRangeOneMember 2017-11-30 0001138978 NVOS:ExercisePriceRangeTwoMember 2017-11-30 0001138978 NVOS:ExercisePriceRangeThreeMember 2017-11-30 0001138978 NVOS:ExercisePriceRangeFourMember 2017-11-30 0001138978 NVOS:ExercisePriceRangeFiveMember 2017-11-30 0001138978 NVOS:NotePayableOneMember 2017-09-01 2017-11-30 0001138978 NVOS:NotePayableTwoMember 2017-09-01 2017-11-30 0001138978 NVOS:NotePayableThreeMember 2017-09-01 2017-11-30 0001138978 NVOS:FiveDebenturesMember 2013-09-30 0001138978 NVOS:FiveDebenturesMember NVOS:CADMember 2017-11-30 0001138978 NVOS:DecemberTwoTwoThousandAndSeventeenMember 2017-09-01 2017-11-30 0001138978 NVOS:DecemberFiveTwoThousandAndSeventeenMember us-gaap:MaximumMember 2017-11-30 0001138978 NVOS:TwoThousandAndFifteenIncentiveCompensationPlanMember us-gaap:MaximumMember 2015-09-07 2015-09-08 0001138978 NVOS:TwoThousandAndFifteenIncentiveCompensationPlanMember 2016-09-01 2017-08-31 0001138978 NVOS:ExercisePriceRangeSixMember 2017-11-30 0001138978 2016-11-30 0001138978 2016-08-31 0001138978 NVOS:PeriodEndMember NVOS:CADMember 2017-11-30 0001138978 NVOS:PeriodEndMember NVOS:CADMember 2016-11-30 0001138978 NVOS:AveragePeriodMember NVOS:CADMember 2017-11-30 0001138978 NVOS:AveragePeriodMember NVOS:CADMember 2016-11-30 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2017-11-30 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenandMayTwentyThreeTwoThousandSeventeenMember 2017-11-30 0001138978 NVOS:AdvanceToCorporationOneMember 2017-11-30 0001138978 NVOS:AdvanceToCorporationTwoMember 2017-11-30 0001138978 NVOS:TwoThousandEighteenMember 2017-09-01 2017-11-30 0001138978 NVOS:ExercisePriceRangeSevenMember 2017-11-30 0001138978 us-gaap:SubsequentEventMember NVOS:AssetPurchaseAgreementMember 2017-11-29 2017-12-01 0001138978 us-gaap:SubsequentEventMember NVOS:FiveDebenturesMember 2017-12-02 0001138978 us-gaap:SubsequentEventMember NVOS:FiveDebenturesMember NVOS:CADMember 2017-12-02 0001138978 us-gaap:SubsequentEventMember 2017-11-29 2017-12-02 0001138978 us-gaap:SubsequentEventMember 2017-12-05 0001138978 us-gaap:SubsequentEventMember 2017-12-04 2017-12-05 0001138978 us-gaap:SubsequentEventMember NVOS:BrandsInternationalCorporationMember 2017-12-26 0001138978 us-gaap:SubsequentEventMember NVOS:BrandsInternationalCorporationMember NVOS:CADMember 2017-12-26 0001138978 us-gaap:SubsequentEventMember NVOS:BrandsInternationalCorporationMember 2017-12-27 2017-12-29 0001138978 us-gaap:SubsequentEventMember NVOS:EmploymentAgreementMember 2017-12-27 2017-12-29 0001138978 us-gaap:SubsequentEventMember NVOS:ShareholderAgreementMember NVOS:MarkRubinoffMember 2017-12-25 2017-12-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD Novo Integrated Sciences, Inc. 0001138978 10-Q 2017-11-30 false --08-31 Smaller Reporting Company Q1 202221364 1896572 1295632 300155 110315 1128898 1288959 372024 380289 39940 299550 32534 291037 31044 58208 252536 192033 3650030 3156913 302951 283874 5514390 4957824 1703342 1574656 341657 360579 403119 437509 1812613 1589001 13171 6073 4273902 3967818 414351 402368 9802580 9339176 201837 201837 3381643 3524308 1240844 1365031 -9091977 -9449265 5514390 4957824 2253737 1818139 1407693 1164113 846044 654026 38139 10301 1018414 591165 -172370 62861 -134102 -106110 -306472 -43249 -54216 -3400 -1727 -357288 -41522 -236501 117894 -0.00 -0.00 201837254 167797406 0.001 0.001 1000000 1000000 0 0 0 0 0.001 0.001 499000000 499000000 201837254 201837254 201837254 201837254 -142665 14998 15580 -82701 -19698 29415 25934 47099 83132 -351815 34453 -23593 362701 -183925 -202485 -41607 -4829 -600940 189840 197389 47705 -54786 -20459 4242 14149 19351 7121 10097 <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table details the exchange rates used for the respective periods:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">November 30, 2017</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">November 30, 2016</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">August 31, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Period end: CAD to USD exchange rate</font></td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.7761</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.7447</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.7988</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Average period: CAD to USD exchange rate</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.7973</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.7537</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> Delaware State of Nevada 2000-11-27 2008-02-20 0.80 167797406 384110 0.7988 0.7761 0.7447 0.7973 0.7537 7980000 P5Y P5Y P3Y P5Y P5Y 0.08 0.75 0.75 2016-09-30 2017-10-31 2019-03-21 2019-04-08 2017-10-31 2019-03-21 2019-04-08 2016-09-30 571056 558958 329985 177514 21020 24319 18218 320607 167524 21345 23628 25854 268105 275084 427522 408441 7134 399400 20988 388050 20391 6073 402368 408441 7860000 7980000 120000 2000000 6920000 0.266 0.268 0.400 0.42 0.259 P3Y6M10D 660000 1797200 1653600 7980000 5500000 1000000 120000 100000 1000000 250000 10000 0.16 0.32 0.40 0.50 0.62 0.80 2.00 6920000 5500000 60000 100000 1000000 250000 10000 0.16 0.32 0.40 0.50 0.62 0.80 2.00 0.015 P2Y6M 3.23 0.00 0.58 0.39 0.42 0.40 142665 2023 191940 193501 0.85 4968990 6402512 4968990 6402512 1873256 2350000 -20537 -23263 -4288190 -4381352 -4267653 -4358089 980275 580864 51 10978 134153 117088 -360688 -43249 124187 161143 6904 507636 474376 0.08 0.08 0.12 0.12 2016-11-15 2016-11-15 2018-05-23 2018-05-23 0.072 0.00 0.06 0.072 0.00 0.06 P3Y4M9D 2018 5114327 4968990 399400 388050 99763 53855 The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price. The per share price to be used for the conversion of each debenture will be the average price of the five trading days immediately preceding the date of conversion with a 10% premium added to the calculated per share price. 5000000 4987500 2019-09-30 2019-09-30 1162009 1128987 376850 <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1 - Organization and Basis of Presentation</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Organization and Line of Business</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Novo Integrated Sciences, Inc. was incorporated in Delaware on November 27, 2000, under the name Turbine Truck Engines, Inc. On February 20, 2008, the Company was re-domiciled to the State of Nevada. Effective July 12, 2017, the Company&#8217;s name was changed to Novo Integrated Sciences, Inc. When used herein, the terms the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Novo Integrated Sciences, Inc. and its consolidated subsidiaries.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We provide specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology and dental services to our clients. Our multi-disciplinary primary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation and prevention through our 14 corporate owned clinics, 150 affiliate clinics, retirement homes, long-term care facilities and institutional locations throughout Canada. Directly and indirectly through our contractual relationships, we provide our specialized services to over 300,000 patients annually. No employee of the Company or any of its subsidiaries practices primary care medicine and the Company&#8217;s services do not require a medical or nursing license.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 25, 2017 (the &#8220;Effective Date&#8221;), the Company entered into a Share Exchange Agreement (the &#8220;Share Exchange Agreement&#8221;) by and between (i) the Company; (ii) NHL, (iii) ALMC-ASAP Holdings Inc. (&#8220;ALMC&#8221;); (iv) Michael Gaynor Family Trust (the &#8220;MGFT&#8221;); (v) 1218814 Ontario Inc. (&#8220;1218814&#8221;) and (vi) Michael Gaynor Physiotherapy Professional Corp. (&#8220;MGPP,&#8221; and together with ALMC, MGFT and 1218814, the &#8220;NHL Shareholders&#8221;). Pursuant to the terms of the Share Exchange Agreement, the Company agreed to acquire from the NHL Shareholders all of the shares of both common and preferred stock of NHL, held by the NHL Shareholders, in exchange for the issuance by the Company to the NHL Shareholders of shares of the Company&#8217;s common stock, such that following the closing of the Share Exchange Agreement, the NHL Shareholders would own 167,797,406 restricted shares of Company common stock, representing 85% of the issued and outstanding Company common stock, calculated including all granted and issued options or warrants to acquire the Company common stock as of the Effective Date, but to exclude shares of Company common stock that are subject to a then-current Regulation S offering that was undertaking by the Company (the &#8220;Exchange&#8221;).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Exchange was accounted for as a reverse acquisition under the purchase method of accounting since NHL obtained control of Novo Integrated Sciences, Inc. Accordingly, the Exchange was recorded as a recapitalization of NHL, with NHL being treated as the continuing entity. The historical financial statements presented are the financial statements of NHL. The Share Exchange Agreement was treated as a recapitalization and not as a business combination; therefore, no pro forma information is disclosed. At the closing date of the Exchange, the net assets of the legal acquirer, Novo Integrated Sciences, Inc., were $6,904.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 9, 2017, our Board of Directors determined, in connection with the closing of the Exchange, to change our fiscal year end from December 31 to August 31, but did not memorialize such determination in writing. On July 17, 2017, the Board ratified and memorialized in writing its May 9, 2017 determination regarding the change in fiscal year end.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The unaudited consolidated financial statements are prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). The information furnished herein reflects all adjustments, consisting only of normal recurring adjustments, which in the opinion of management, are necessary to fairly state the Company&#8217;s financial position, the results of its operations, and cash flows for the periods presented. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) were omitted pursuant to such rules and regulations. The results of operations for the three months ended November 30, 2017 are not necessarily indicative of the results for the year ending August 31, 2018.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of Presentation</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements were prepared in conformity with U.S. GAAP. The Company&#8217;s Canadian subsidiaries&#8217; functional currency is the Canadian Dollar (&#8220;CAD&#8221;); however, the accompanying consolidated financial statements were translated and presented in United States Dollars (&#8220;$&#8221; or &#8220;USD&#8221;).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Foreign Currency Translation</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accounts of the Company&#8217;s Canadian subsidiaries are maintained in CAD. The accounts of these subsidiaries are translated into USD in accordance with ASC Topic 830&#160;<i>Foreign Currency Transaction</i>, with the CAD as the functional currency. According to Topic 830, all assets and liabilities are translated at the exchange rate on the balance sheet date, stockholders&#8217; equity is translated at historical rates and statement of operations items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220,&#160;<i>Comprehensive Income</i>. Gains and losses resulting from the translations of foreign currency transactions and balances are reflected in the statement of operations and comprehensive income. The following table details the exchange rates used for the respective periods:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">November 30, 2017</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">November 30, 2016</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">August 31, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Period end: CAD to USD exchange rate</font></td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.7761</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.7447</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.7988</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Average period: CAD to USD exchange rate</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.7973</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.7537</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 &#8211; Summary of Significant Accounting Policies</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company&#8217;s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Principles of Consolidation</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, NHL, Novo Peak Health Inc., Novo Healthnet Rehab Limited, Novo Assessments Inc., an 80% interest in Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, and a fifty percent stake in a joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated as Novo Dental. All of the Company&#8217;s subsidiaries are incorporated under the laws of the Province of Ontario, Canada. All intercompany transactions have been eliminated.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Noncontrolling Interest</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810,&#160;<i>Consolidation,</i>&#160;which governs the accounting for and reporting of non-controlling interests (&#8220;NCIs&#8221;) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent&#8217;s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash Equivalents</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are recorded, net of allowance for doubtful accounts and sales returns. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentration, customer credit worthiness, current economic trends and changes in customer payment patterns to determine if the allowance for doubtful accounts is adequate. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Delinquent account balances are written-off after management has determined that the likelihood of collection is not probable and known bad debts are written off against the allowance for doubtful accounts when identified. As of November 30, 2017 and August 31, 2017, the allowance for uncollectible accounts receivable was $474,376 and $507,636, respectively.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Property and Equipment</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 61%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</font></td> <td style="width: 39%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Clinical equipment</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Computer equipment</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Office equipment</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Long-Lived Assets</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the provisions of ASC Topic 360,&#160;<i>Property, Plant, and Equipment</i>, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets&#8217; carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at November 30, 2017 and August 31, 2017, the Company believes there was no impairment of its long-lived assets.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Goodwill</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. Under accounting requirements, goodwill is not amortized but is subject to annual impairment tests. The Company recorded goodwill of $388,050 at November 30, 2017 related to its acquisition of Apka Health, Inc. during fiscal year ended August 31, 2017. As of August 31, 2017, the Company performed the required impairment review. Based on its review at August 31, 2017, the Company believes there was no impairment of its goodwill.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Acquisition Deposits</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,128,987 at November 30, 2017.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair Value of Financial Instruments</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For certain of the Company&#8217;s financial instruments, including cash and equivalents, restricted cash, accounts receivable, advances to suppliers, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">FASB ASC Topic 820,&#160;<i>Fair Value Measurements and Disclosures</i>, requires disclosure of the fair value of financial instruments held by the Company. FASB ASC Topic 825,&#160;<i>Financial Instruments</i>, defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; line-height: 107%">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the fair value measurement.</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480,&#160;<i>Distinguishing Liabilities from Equity</i>, and FASB ASC Topic 815,&#160;<i>Derivatives and Hedging</i>.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2017 and August 31, 2017, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider&#8217;s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company&#8217;s revenue policies meet the following four criteria in accordance with FASB ASC 605,&#160;<i>Revenue Recognition</i>: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income Taxes</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes in accordance with ASC Topic 740,&#160;<i>Income Taxes</i>. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Under ASC 740, a tax position is recognized as a benefit only if it is &#8220;more likely than not&#8221; that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the &#8220;more likely than not&#8221; test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-Based Compensation</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records stock-based compensation in accordance with FASB ASC Topic 718,&#160;<i>Compensation &#8211; Stock Compensation</i>. FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at fair value at the grant date and recognize the expense over the requisite service period. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basic and Diluted Earnings Per Share</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Earnings per share is calculated in accordance with ASC Topic 260,&#160;<i>Earnings Per Share</i>. Basic earnings per share (&#8220;EPS&#8221;) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. There were 7,980,000 options/warrants outstanding as of November 30, 2017. Due to the net loss incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Foreign Currency Transactions and Comprehensive Income</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company&#8217;s Canadian subsidiaries is the Canadian $. Translation gains of $1,365,031 and $1,240,844 at November 30, 2017 and August 31, 2017, respectively, are classified as an item of other comprehensive income in the stockholders&#8217; equity section of the balance sheet.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Statement of Cash Flows</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash flows from the Company&#8217;s operations are calculated based upon the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2017, the FASB issued an Accounting Standards Update (&#8220;ASU&#8221;) 2017-01,&#160;<i>Business Combinations (Topic 805) Clarifying the Definition of a Business</i>. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2016, the FASB issued ASU 2016-18,&#160;<i>Statement of Cash Flows (Topic 230): Restricted Cash,</i>&#160;which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2016, the FASB issued ASU 2016-16,&#160;<i>Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory</i>, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2016, the FASB issued ASU 2016-15,&#160;<i>Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments</i>. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,&#160;<i>Leases (Topic 842)</i>. ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09,&#160;<i>Revenue from Contracts with Customers</i>. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company&#8217;s financial statements and disclosures.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 &#8211; Related Party Transactions</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Due to related parties</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Amounts loaned to the Company by stockholders and officers of the Company that are non-interest bearing and payable upon demand.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4 &#8211; Other Receivables</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Other receivables at November 30, 2017 and August 31, 2017 consisted of the following:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">November 30, 2017</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">August 31, 2017</font></td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; due November 15, 2016.</font></td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">39,940</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 12% per annum; secured by certain assets; due May 23, 2018.</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">291,037</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">299,550</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Advance to corporation; non-interest bearing; unsecured; payable upon demand</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">31,044</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">32,534</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Advance to corporation; non-interest bearing; unsecured; payable upon demand</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">58,208</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Total other receivables</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">380,289</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">372,024</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5 &#8211; Property and Equipment</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment at November 30, 2017 and August 31, 2017 consisted of the following:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">November 30, 2017</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">August 31, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Leasehold Improvements</font></td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">320,607</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">329,985</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Clinical equipment</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">167,524</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">177,514</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Computer equipment</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">21,345</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">21,020</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Office equipment</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">23,628</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">24,319</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Furniture and fixtures</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">25,854</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">18,218</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">558,958</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">571,056</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Accumulated depreciation</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">(275,084</font></td> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">(268,105</font></td> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Total</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">283,874</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">302,951</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense for the three months ended November 30, 2017 and 2016 was $14,998 and $15,580, respectively.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6 &#8211; Notes Payable</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable at November 30, 2017 and August 31, 2017 consisted of the following:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">November 30, 2017</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">August 31, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017. This note has been fully repaid.</font></td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 17%; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">7,134</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 21, 2019.</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">388,050</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">399,400</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Notes payable assumed with acquisition; accrues interest at 6% per annum; monthly principal and interest payment of $619; unsecured; due April 8, 2019.</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">20,391</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">20,988</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">408,441</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">427,522</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Current portion</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">(6,073</font></td> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">(13,171</font></td> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Long-term portion</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">402,368</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">414,351</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Aggregate future maturities of notes payable as of November 30 are as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Twelve months ending November 30,</font></td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">6,073</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">402,368</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">408,441</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7 &#8211; Debentures, related parties</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 30, 2013, the Company issued five debentures totaling $4,968,990 (CAD$6,402,512) at November 30, 2017 in connection with the acquisition of certain business assets. The holders of the debentures are current stockholders, officers and/or affiliates of the Company. The debentures are secured by all the assets of the Company, accrue interest at 8% per annum and were originally due on September 30, 2016. On December 2, 2017, the debenture holders agreed to extend the due date to September 30, 2019. On December 5, 2017, the debenture holders and the Company signed a binding Letter of Intent to convert no less than seventy-five percent (75%) of the debenture value plus any interest or fees owed to the Company&#8217;s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 8 &#8211; Stockholders&#8217; Deficit</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Convertible preferred stock</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has authorized 1,000,000 shares of $0.001 par value convertible preferred stock. At November 30, 2017 and August 31, 2017 there were 0 and 0 convertible preferred shares issued and outstanding, respectively.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common stock</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has authorized 499,000,000 shares of $0.001 par value common stock. At November 30, 2017 and August 31, 2017 there were 201,837,254 and 201,837,254 common shares issued and outstanding, respectively.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock options/warrants</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 8, 2015, the Company adopted the 2015 Incentive Compensation Plan (the &#8220;2015 Plan&#8221;), which authorizes the issuance of up to 5,000,000 shares of common stock to employees, officers, directors or independent consultants of the Company, provided that no person can be granted shares under the 2015 Plan for services related to raising capital or promotional activities. During 2017 and 2016, the Company did not grant any awards under the 2015 Plan. As of August 31, 2017, 4,987,500 shares were available under the 2015 Plan for future grants, awards, options or share issuances. However, because the shares issuable under the 2015 Plan or issuable upon conversion of awards granted under the Plan are no longer registered under the Securities Exchange Act of 1934, as amended, the Company does not intend to issue any additional grants under the 2015 Plan.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of stock option/warrant activity:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options/</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Remaining</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Aggregate</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrants</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Contractual</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Intrinsic</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Life</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 39%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, August 31, 2017</font></td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 12%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,860,000</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 12%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.266</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3.53</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">660,000</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">120,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.400</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, November 30, 2017</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,980,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.268</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3.56</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,797,200</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable, November 30, 2017</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">6,920,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.259</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3.36</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,653,600</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The exercise price for options/warrants outstanding at November 30, 2017:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercisable</b></font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options/</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options/</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrants</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrants</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 22%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5,500,000</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 21%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.16</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 22%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5,500,000</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 21%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.16</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.32</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.32</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">120,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.40</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">60,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.40</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.50</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.50</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.62</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.62</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">250,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.80</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">250,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.80</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">10,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2.00</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">10,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2.00</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,980,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">6,920,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For options granted during fiscal year 2017 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.58 and the weighted-average exercise price of such options/warrants was $0.42. No options were granted during fiscal 2017 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For options granted during fiscal year 2018 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.39 and the weighted-average exercise price of such options/warrants was $0.40. No options were granted during fiscal 2018 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the stock options is being amortized to stock option expense over the vesting period. The Company recorded stock option expense of $142,665 during the three months ended November 30, 2017. At November 30, 2017, the unamortized stock option expense was $286,413.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 86%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1.5</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expected life of the options</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2.5 years</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">323</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expected dividend yield</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 9 &#8211; Commitments and Contingencies</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Litigation</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is party to certain legal proceedings from time to time incidental to the conduct of its business. These proceedings could result in fines, penalties, compensatory or treble damages or non-monetary relief. The nature of legal proceedings is such that the Company cannot assure the outcome of any particular matter, and an unfavorable ruling or development could have a materially adverse effect on our consolidated financial position, results of operations and cash flows in the period in which a ruling or settlement occurs. However, based on information available to the Company&#8217;s management to date, the Company&#8217;s management does not expect that the outcome of any matter pending against the Company is likely to have a materially adverse effect on the Company&#8217;s consolidated financial position as of November 30, 2017, results of operations, cash flows or liquidity of the Company.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Leases</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company leases its office space and certain facilities under long-term operating leases expiring through fiscal year 2023. Rent expense under these leases was $191,940 and $193,501 for the three months ended November 30, 2017 and 2016, respectively.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 10 &#8211; Subsequent Events</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 1, 2017, the Company and Executive Fitness Leaders<font style="background-color: white">, located in Ottawa Ontario Canada,&#160;</font>entered into an Asset Purchase Agreement, pursuant to which the Company acquired substantially all of the assets of Executive Fitness Leaders in exchange for the issuance, by the Company, of 384,110 restricted shares of its common stock valued at approximately $233,155. The transaction closed on December 1, 2017. The purchase of these assets was not considered significant for accounting purposes; therefore, pro forma financial statements are not presented.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 2, 2017, the Company and certain related party debenture holders of five debentures totaling $4,968,990 (CAD$6,402,512) dated September 30, 2013 with an original due date of September 30, 2016 (see Note 7 for further details) agreed to extend the due date of the debentures to September 30, 2019.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 5, 2017, the related party debenture holders and the Company signed a binding Letter of Intent to convert no less than 75% of the debenture value, plus any interest or fees owed, to the Company&#8217;s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five trading days immediately preceding the date of conversion with a 10% premium added to the calculated per share price.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 26, 2017, the Company entered into a binding letter of intent (the &#8220;LOI&#8221;) with Brands International Corporation (&#8220;Brands&#8221;), pursuant to which the Company agreed to acquire 60% of the issued and outstanding shares of Brands in exchange for the arrangement of secured debt financing in the amount of CAD$2,350,000 (approximately $1,873,256 per the Bank of Canada posted exchange rate of 0.7977 on December 29, 2017) arranged or provided by the Company (the &#8220;Acquisition&#8221;). Upon completion of the Acquisition, the Company will own 60% of Brands&#8217; issued and outstanding shares and Brands will be a partially-owned subsidiary of the Company. In connection with the Acquisition, the Company will enter into a shareholder agreement with Mark Rubinoff and a management agreement with Mark Rubinoff and DJ Robinoff. In addition, pursuant to the terms of the LOI, the Company agreed to provide Mark Rubinoff with a buyout structure for the remaining 40% of Brands&#8217; shares with a trigger date of 24 months from the closing of the Acquisition.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The parties to the LOI agreed to proceed reasonably and in good faith toward negotiation and execution of a definitive acquisition agreement (a &#8220;Definitive Agreement&#8221;), and to use their commercially reasonable best efforts to obtain necessary board, stockholder and regulatory approvals and third party consents.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The parties to the LOI also agreed that from the date of the LOI until the earlier of January 30, 2018 (the &#8220;Termination Date&#8221;) and the date the parties enter into a Definitive Agreement, the parties and their respective directors, officers, agents and representatives will not:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify; line-height: 107%">&#160;</td> <td style="width: 24px; text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">solicit, initiate or encourage the initiation of any expression of interest, inquiries or proposals regarding, constituting or that may reasonably be expected to lead to any merger, amalgamation, takeover bid, tender offer, arrangement, recapitalization, liquidations, dissolution, share exchange, sale of material assets involving the parties or a proposal or offer to do so (the &#8220;Acquisition Proposal&#8221;) (including without limitation, any grant of an option or other right to take any such action);</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">participate in any discussions or negotiations regarding an Acquisition Proposal;</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">accept or enter into, or propose publicly to accept or enter into, any agreement, letter of intent, memorandum of understanding or any arrangement in respect of an Acquisition Proposal; and</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">otherwise cooperate in any way, assist or participate in, facilitate or encourage any effort or attempt by any person to do any of the foregoing.</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, Brands agreed not to solicit funds in any secured or unsecured debt form resulting in a change in the company&#8217;s financials unless the Company is made aware of such solicitation in writing.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">If the Definitive Agreement is not negotiated and executed by both parties on or before the Termination Date, or such other date as agreed to by the parties in writing, the terms of the LOI will be of no further force or effect except for the confidentiality, costs and governing laws provisions, which sections will remain in effect for a period of one year following the date on which the LOI is terminated.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 29, 2017, the Company entered into an employment agreement (the &#8220;Employment Agreement&#8221;) with Christopher David, the Company&#8217;s President and a member of the board of directors, effective January 1, 2018. The Employment Agreement terminates on July 30, 2018, subject to the termination provisions contained in the Employment Agreement.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the terms of the Employment Agreement, Mr. David agreed to serve as the Company&#8217;s President. In consideration thereof, the Company agreed to (i) pay Mr. David a monthly salary of $8,000, and (ii) grant Mr. David a 5-year option (the &#8220;Option&#8221;) to purchase 2,000,000 shares of the Company&#8217;s restricted common stock at an exercise price of $0.42 per share. The Option vested on December 29, 2017.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the terms of the Employment Agreement, the Company may terminate Mr. David at any time, with or without Cause (as defined below); provided, however, that if the Company terminates Mr. David without Cause:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">(a) The Option shall be deemed fully vested effective as of December 29, 2017, and is not subject to revocation or return, and</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">(b) The Company will continue to owe Mr. David his monthly salary through July 30, 2018.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#8220;Cause&#8221; means Mr. David must have (i) been willful, gross or persistent in his inattention to his duties or he committed acts which constitute willful or gross misconduct and, after written notice of the same, has been given the opportunity to cure the same within 30 days after such notice, and (ii) been found guilty of having committed a fraud against the Company.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 29, 2017, the Company granted the Option to Mr. David pursuant to that certain Option to Purchase Common Stock (the &#8220;Option Agreement&#8221;). The Option Agreement provides for the cashless exercise of all or a portion of the Option, or exercise through payment of the exercise price in cash.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company&#8217;s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Principles of Consolidation</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, NHL, Novo Peak Health Inc., Novo Healthnet Rehab Limited, Novo Assessments Inc., an 80% interest in Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, and a fifty percent stake in a joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated as Novo Dental. All of the Company&#8217;s subsidiaries are incorporated under the laws of the Province of Ontario, Canada. All intercompany transactions have been eliminated.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Noncontrolling Interest</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810,&#160;<i>Consolidation,</i>&#160;which governs the accounting for and reporting of non-controlling interests (&#8220;NCIs&#8221;) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent&#8217;s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash Equivalents</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are recorded, net of allowance for doubtful accounts and sales returns. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentration, customer credit worthiness, current economic trends and changes in customer payment patterns to determine if the allowance for doubtful accounts is adequate. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Delinquent account balances are written-off after management has determined that the likelihood of collection is not probable and known bad debts are written off against the allowance for doubtful accounts when identified. As of November 30, 2017 and August 31, 2017, the allowance for uncollectible accounts receivable was $474,376 and $507,636, respectively.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Property and Equipment</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 61%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</font></td> <td style="width: 39%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Clinical equipment</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Computer equipment</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Office equipment</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Long-Lived Assets</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the provisions of ASC Topic 360,&#160;<i>Property, Plant, and Equipment</i>, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets&#8217; carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at November 30, 2017 and August 31, 2017, the Company believes there was no impairment of its long-lived assets.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Goodwill</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. Under accounting requirements, goodwill is not amortized but is subject to annual impairment tests. The Company recorded goodwill of $388,050 at November 30, 2017 related to its acquisition of Apka Health, Inc. during fiscal year ended August 31, 2017. As of August 31, 2017, the Company performed the required impairment review. Based on its review at August 31, 2017, the Company believes there was no impairment of its goodwill.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Acquisition Deposits</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,128,987 at November 30, 2017.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair Value of Financial Instruments</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For certain of the Company&#8217;s financial instruments, including cash and equivalents, restricted cash, accounts receivable, advances to suppliers, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">FASB ASC Topic 820,&#160;<i>Fair Value Measurements and Disclosures</i>, requires disclosure of the fair value of financial instruments held by the Company. FASB ASC Topic 825,&#160;<i>Financial Instruments</i>, defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; line-height: 107%">&#160;</td> <td style="width: 24px; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the fair value measurement.</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480,&#160;<i>Distinguishing Liabilities from Equity</i>, and FASB ASC Topic 815,&#160;<i>Derivatives and Hedging</i>.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November 30, 2017 and August 31, 2017, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider&#8217;s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company&#8217;s revenue policies meet the following four criteria in accordance with FASB ASC 605,&#160;<i>Revenue Recognition</i>: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income Taxes</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes in accordance with ASC Topic 740,&#160;<i>Income Taxes</i>. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Under ASC 740, a tax position is recognized as a benefit only if it is &#8220;more likely than not&#8221; that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the &#8220;more likely than not&#8221; test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basic and Diluted Earnings Per Share</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Earnings per share is calculated in accordance with ASC Topic 260,&#160;<i>Earnings Per Share</i>. Basic earnings per share (&#8220;EPS&#8221;) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. There were 7,980,000 options/warrants outstanding as of November 30, 2017. Due to the net loss incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Foreign Currency Transactions and Comprehensive Income</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company&#8217;s Canadian subsidiaries is the Canadian $. Translation gains of $1,365,031 and $1,240,844 at November 30, 2017 and August 31, 2017, respectively, are classified as an item of other comprehensive income in the stockholders&#8217; equity section of the balance sheet.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Statement of Cash Flows</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash flows from the Company&#8217;s operations are calculated based upon the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2017, the FASB issued an Accounting Standards Update (&#8220;ASU&#8221;) 2017-01,&#160;<i>Business Combinations (Topic 805) Clarifying the Definition of a Business</i>. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2016, the FASB issued ASU 2016-18,&#160;<i>Statement of Cash Flows (Topic 230): Restricted Cash,</i>&#160;which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2016, the FASB issued ASU 2016-16,&#160;<i>Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory</i>, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2016, the FASB issued ASU 2016-15,&#160;<i>Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments</i>. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,&#160;<i>Leases (Topic 842)</i>. ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09,&#160;<i>Revenue from Contracts with Customers</i>. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company&#8217;s financial statements and disclosures.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 61%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</font></td> <td style="width: 39%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Clinical equipment</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Computer equipment</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Office equipment</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Other receivables at November 30, 2017 and August 31, 2017 consisted of the following:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">November 30, 2017</font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">August 31, 2017</font></td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; due November 15, 2016.</font></td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">39,940</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 12% per annum; secured by certain assets; due May 23, 2018.</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">291,037</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">299,550</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Advance to corporation; non-interest bearing; unsecured; payable upon demand</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">31,044</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">32,534</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Advance to corporation; non-interest bearing; unsecured; payable upon demand</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">58,208</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Total other receivables</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">380,289</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">372,024</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment at November 30, 2017 and August 31, 2017 consisted of the following:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">November 30, 2017</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">August 31, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Leasehold Improvements</font></td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">320,607</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">329,985</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Clinical equipment</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">167,524</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">177,514</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Computer equipment</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">21,345</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">21,020</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Office equipment</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">23,628</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">24,319</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Furniture and fixtures</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">25,854</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">18,218</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">558,958</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">571,056</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Accumulated depreciation</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">(275,084</font></td> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">(268,105</font></td> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">Total</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">283,874</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt Times New Roman, Times, Serif">302,951</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable at November 30, 2017 and August 31, 2017 consisted of the following:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">November 30, 2017</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">August 31, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017. This note has been fully repaid.</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 16%; text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">7,134</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 21, 2019.</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">388,050</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">399,400</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">Notes payable assumed with acquisition; accrues interest at 6% per annum; monthly principal and interest payment of $619; unsecured; due April 8, 2019.</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">20,391</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">20,988</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">408,441</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">427,522</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">Current portion</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">(6,073</font></td> <td style="line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">)</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">(13,171</font></td> <td style="line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">Long-term portion</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">402,368</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 9pt/106% Times New Roman, Times, Serif">414,351</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Aggregate future maturities of notes payable as of November 30 are as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Twelve months ending November 30,</font></td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">6,073</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">402,368</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">408,441</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of stock option/warrant activity:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options/</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Remaining</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Aggregate</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrants</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Contractual</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Intrinsic</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Life</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="text-align: center; line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td> <td style="text-align: center; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 39%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, August 31, 2017</font></td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 12%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,860,000</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 12%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.266</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3.53</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">660,000</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">120,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.400</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, November 30, 2017</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,980,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.268</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3.56</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,797,200</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable, November 30, 2017</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">6,920,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.259</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">3.36</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,653,600</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The exercise price for options/warrants outstanding at November 30, 2017:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercisable</b></font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options/</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options/</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrants</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrants</b></font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 22%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5,500,000</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 21%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.16</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 22%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5,500,000</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 2%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 21%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.16</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.32</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.32</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">120,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.40</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">60,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.40</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.50</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.50</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.62</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.62</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">250,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.80</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">250,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0.80</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">10,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2.00</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">10,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2.00</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">7,980,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">6,920,000</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 86%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 11%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">1.5</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expected life of the options</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2.5 years</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">323</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Expected dividend yield</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> </table> <p style="margin: 0pt"></p> 176804 192388 3567 619 3567 619 286413 P3Y6M21D 233155 Bank of Canada posted exchange rate of 0.7977 on December 29, 2017 8000 P5Y NVOS <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-Based Compensation</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records stock-based compensation in accordance with FASB ASC Topic 718,&#160;<i>Compensation &#8211; Stock Compensation</i>. FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at fair value at the grant date and recognize the expense over the requisite service period. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees.</p> 0.60 0.40 EX-101.SCH 6 nvos-20171130.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (loss) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Organization and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Other Receivables link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Debentures, Related Parties link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Organization and Basis of Presentation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Other Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Stockholders' Deficit (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Organization and Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Notes Payable - Schedule of Future Maturities of Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Debentures, Related Parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Stockholders’ Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Stockholders’ Deficit - Schedule of Stock Option and Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Stockholders’ Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Stockholders’ Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 nvos-20171130_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 nvos-20171130_def.xml XBRL DEFINITION FILE EX-101.LAB 9 nvos-20171130_lab.xml XBRL LABEL FILE Legal Entity [Axis] Turbine Truck Engines, Inc [Member] Turbine Truck Engines, Inc One [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Share Exchange Agreement [Member] NHL [Member] Report Date [Axis] Period End [Member] Currency [Axis] CAD [Member] Novo Healthnet Kemptville Centre, Inc [Member] Property, Plant and Equipment, Type [Axis] Leasehold Improvements [Member] Clinical Equipment [Member] Computer Equipment [Member] Office Equipment [Member] Furniture and Fixtures [Member] Receivable Type [Axis] Notes Receivable Dated November 15, 2014 [Member] Notes Receivable Dated April 1, 2015 and May 23, 2017 [Member] Advance to Corporation One [Member] Advance to Corporation Two [Member] Debt Instrument [Axis] Note Payable One [Member] Note Payable Two [Member] Note Payable Three [Member] Exercise Price Range [Axis] Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Three [Member] Exercise Price Range Four [Member] Exercise Price Range Five [Member] Five Debentures [Member] December 2, 2017 [Member] December 5, 2017 [Member] Range [Axis] Maximum [Member] Plan Name [Axis] 2015 Incentive Compensation Plan [Member] Exercise Price Range Six [Member] Average Period [Member] Award Date [Axis] 2018 [Member] Exercise Price Range Seven [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Asset Purchase Agreement [Member] Brands International Corporation [Member] Employment Agreement [Member] Shareholder Agreement [Member] Title of Individual [Axis] Mark Rubinoff [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets: Cash and cash equivalents Accounts receivable, net Other receivables Prepaid expenses and other current assets Total current assets Property and equipment, net Acquisition deposits Goodwill TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities: Accounts payable Accrued expenses Accrued interest (principally to related parties) Due to related parties Notes payable, current portion Total current liabilities Debentures, related parties Notes payable, net of current portion TOTAL LIABILITIES Commitments and contingencies (Note 9) STOCKHOLDERS' DEFICIT Novo Integrated Sciences, Inc. Convertible Preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at November 30, 2017 and August 31, 2017 Common stock; $0.001par value; 499,000,000 shares authorized; 201,837,254 and 201,837,254 shares issued and outstanding at November 30, 2017 and August 31, 2017 Additional paid-in capital Other comprehensive income Accumulated deficit Total Novo Integrated Sciences, Inc. stockholders' deficit Noncontrolling interest Total stockholders' deficit TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT Convertible preferred stock, par value Convertible preferred stock, shares authorized Convertible preferred stock, shares issued Convertible preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Cost of revenues Gross profit Operating expenses: Selling expenses General and administrative expenses Total operating expenses Income (loss) from operations Non operating income (expense) Interest income Interest expense Total other income (expense) Loss before income taxes Income tax expense Net loss Net loss attributed to noncontrolling interest Net loss attributed to Novo Integrated Sciences, Inc. Comprehensive income (loss): Net loss Foreign currency translation gain Comprehensive income (loss): Weighted average common shares outstanding - basic and diluted Net loss per common share - basic and diluted Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Depreciation Fair value of vested stock options Changes in operating assets and liabilities: Accounts receivable Prepaid expenses and other current assets Accounts payable Accrued expenses Accrued interest Net cash provided by (used in) operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of furniture and equipment Amounts loaned for other receivables Repayments of other receivables Net cash provided by (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Repayments from related parties Payments on notes payable Net cash used in financing activities Effect of exchange rate changes on cash and equivalents NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS, END OF PERIOD CASH PAID FOR: Interest Income taxes Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Basis of Presentation Accounting Policies [Abstract] Summary of Significant Accounting Policies Related Party Transactions [Abstract] Related Party Transactions Receivables [Abstract] Other Receivables Property, Plant and Equipment [Abstract] Property and Equipment Debt Disclosure [Abstract] Notes Payable Debentures, Related Parties Equity [Abstract] Stockholders' Deficit Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Use of Estimates Principles of Consolidation Noncontrolling Interest Cash Equivalents Accounts Receivable Property and Equipment Long-lived Assets Goodwill Acquisition Deposits Fair Value of Financial Instruments Revenue Recognition Income Taxes Stock-Based Compensation Basic and Diluted Earnings Per Share Foreign Currency Transactions and Comprehensive Income Statement of Cash Flows Recent Accounting Pronouncements Schedule of Foreign Currency Translation, Exchange Rate Used Schedule of Estimated Useful Lives of Assets Schedule of Other Receivables Schedule of Property and Equipment Schedule of Notes Payable Schedule of Future Maturities of Notes Payable Schedule of Stock Option and Warrant Activity Schedule of Options and Warrants Outstanding and Exercisable Schedule of Fair Value of Options Granted by Using Valuation Assumptions Statement [Table] Statement [Line Items] State country name Date of incorporation Number of restricted shares of common stock Percentage of common stock issued and outstanding Common stock issued in connection with reverse merger transaction Foreign currency exchange rate Equity method investment, ownership percentage Allowance for uncollectible accounts receivable Potentially dilutive common stock options and warrants outstanding, shares Gain on foreign currency transactions Property and equipment, estimated lives Total other receivables Percentage of accrues interest per annum Notes receivable due date Depreciation expense Property and equipment, gross Accumulated depreciation Total Note payable Current portion Long-term portion Percentage of accrues interest per annum Notes payable, due date Debt periodic payment 2018 2019 Total Debentures, related parties Debt interest rate Debt due date Debt extended due date Debt conversion description Convertible Preferred stock shares authorized Convertible Preferred stock par value Convertible Preferred stock shares issued Convertible Preferred stock shares outstanding Common stock shares authorized Common stock par value Common stock shares issued Common stock shares outstanding Number of common stock shares issued Number of shares issued for granted Stock options granted weighted-average grant date fair value Stock options/warrants weighted-average exercise Stock option expense Unamortized stock option expense Options/Warrants Outstanding, Beginning balance Options/Warrants Outstanding, Granted Options/Warrants Outstanding, Forfeited Options/Warrants Outstanding, Exercised Options/Warrants Outstanding, Ending balance Options/Warrants Outstanding, Exercisable Weighted Average Exercise Price, Beginning balance Weighted Average Exercise Price, Granted Weighted Average Exercise Price, Ending balance Weighted Average Exercise Price, Exercisable Weighted Average Remaining Contractual Life, Outstanding, Beginning balance Weighted Average Remaining Contractual Life, Outstanding, Ending balance Weighted Average Remaining Contractual Life, Exercisable Aggregate Intrinsic Value, Outstanding, Beginning balance Aggregate Intrinsic Value, Outstanding, Ending balance Aggregate Intrinsic Value, Exercisable Number of Options/Warrants, Outstanding Number of Options/Warrants, Outstanding, Exercise Price Number of Options/Warrants, Exercisable Number of Options/Warrants, Exercisable, Exercise Price Risk-free interest rate Expected life of the options Expected volatility Expected dividend yield Operating leases expiration date Rent expense Number of restricted shares issued Number of restricted shares issued value Percentage acquired for issued and outstanding shares Bank exchange rate, description Monthly salary Option term Number of options granted to purchase shares of common stock Stock option exercise price Total Novo Stockholders Deficit [Member] Debentures, Related Parties Disclosure [Text Block] Noncontrolling Interest Disclosure [Policy Text Block] Statement of Cash Flows Disclosure [Policy Text Block] Schedule of Foreign Currency Translation, Exchange Rate Used [Table Text Block] Schedule of Estimated Useful Lives of Assets [Table Text Block] Schedule of Other Receivables [Table Text Block] Turbine Truck Engines, Inc [Member] Turbine Truck Engines, Inc One [Member] Novo Assessments, Inc, Novo Healthnet Rehab Limited, Novo Peak Health, Inc [Member] Novo Healthnet Kemptville Centre, Inc [Member] Share Exchange Agreement [Member] NHL [Member] Percentage of common stock issued and outstanding. Period End [Member] CAD [Member] Average Period [Member] Clinical Equipment [Member] Notes Receivable Dated November 15, 2014 [Mermber] Notes Receivable Dated May 23, 2017 [Mermber] Notes Receivable Dated April 1, 2015 [Mermber] Advance to Corporation One [Mermber] Advance to Corporation Two [Mermber] Note Payable One [Member] Note Payable Two [Member] Note Payable Three [Member] Note Payable Four [Member] Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Three [Member] Exercise Price Range Four [Member] Exercise Price Range Five [Member] Operating leases expiration date. Common Stock Payable [Member] Deferred Non Cash Offering Costs [Member] Prepaid Consulting Services Paid For With Common Stock [Member] Subscription Receivable [Member] 2015 Incentive Compensation Plan [Member] 2015 Plan [Member] Sahoma Controlware LLC [Member] Services Agreement [Member] Robert Barbara Scragg And Alpha EnginesInc [Member] Financing Agreement [Member] Ontario, Inc., [Member] Board of Directors [Member] Loan Agreement [Member] From June 19,2013 Through October 1, 2014 [Member] Transaction 1 [Member] Transaction 2 [Member] Transaction 3 [Member] Transaction 4 [Member] Transaction 5 [Member] Acquisition Deposits [Policy Text Block] Notes Receivable Dated April 1, 2015 and May 23, 2017 [Mermber] Five Debentures [Member] December 2, 2017 [Member] December 5, 2017 [Member] 2015 Incentive Compensation Plan [Member] Exercise Price Range Six [Member] United States [Member] Canada [Member] Debt extended due date. 2018 [Member] Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Exercise Price Range Seven [Member] Asset Purchase Agreement [Member] Brands International Corporation [Member] Shareholder Agreement [Member] Mark Rubinoff [Member] Employment Agreement [Member] Bank exchange rate, description. Option term. Percentage acquired for issued and outstanding shares. Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Tax Expense (Benefit) Net Income (Loss) Attributable to Parent Comprehensive Income (Loss), Net of Tax, Attributable to Parent Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Payments to Acquire Property, Plant, and Equipment Payments for (Proceeds from) Loans Receivable Net Cash Provided by (Used in) Investing Activities, Continuing Operations Repayments of Related Party Debt Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash and Cash Equivalents, Period Increase (Decrease) Property, Plant and Equipment, Policy [Policy Text Block] Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Debt Instrument, Interest Rate During Period Long-term Debt Secured Debt, Current Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value EX-101.PRE 10 nvos-20171130_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document and Entity Information - shares
3 Months Ended
Nov. 30, 2017
Jan. 09, 2018
Document And Entity Information    
Entity Registrant Name Novo Integrated Sciences, Inc.  
Entity Central Index Key 0001138978  
Document Type 10-Q  
Document Period End Date Nov. 30, 2017  
Amendment Flag false  
Current Fiscal Year End Date --08-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   202,221,364
Trading Symbol NVOS  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2018  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
Nov. 30, 2017
Aug. 31, 2017
Current Assets:    
Cash and cash equivalents $ 1,295,632 $ 1,896,572
Accounts receivable, net 1,288,959 1,128,898
Other receivables 380,289 372,024
Prepaid expenses and other current assets 192,033 252,536
Total current assets 3,156,913 3,650,030
Property and equipment, net 283,874 302,951
Acquisition deposits 1,128,987 1,162,009
Goodwill 388,050 399,400
TOTAL ASSETS 4,957,824 5,514,390
Current Liabilities:    
Accounts payable 1,574,656 1,703,342
Accrued expenses 360,579 341,657
Accrued interest (principally to related parties) 437,509 403,119
Due to related parties 1,589,001 1,812,613
Notes payable, current portion 6,073 13,171
Total current liabilities 3,967,818 4,273,902
Debentures, related parties 4,968,990 5,114,327
Notes payable, net of current portion 402,368 414,351
TOTAL LIABILITIES 9,339,176 9,802,580
Commitments and contingencies (Note 9)
Novo Integrated Sciences, Inc.    
Common stock; $0.001par value; 499,000,000 shares authorized; 201,837,254 and 201,837,254 shares issued and outstanding at November 30, 2017 and August 31, 2017 201,837 201,837
Additional paid-in capital 3,524,308 3,381,643
Other comprehensive income 1,365,031 1,240,844
Accumulated deficit (9,449,265) (9,091,977)
Total Novo Integrated Sciences, Inc. stockholders' deficit (4,358,089) (4,267,653)
Noncontrolling interest (23,263) (20,537)
Total stockholders' deficit (4,381,352) (4,288,190)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 4,957,824 $ 5,514,390
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Nov. 30, 2017
Aug. 31, 2017
Statement of Financial Position [Abstract]    
Convertible preferred stock, par value $ 0.001 $ 0.001
Convertible preferred stock, shares authorized 1,000,000 1,000,000
Convertible preferred stock, shares issued 0 0
Convertible preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 499,000,000 499,000,000
Common stock, shares issued 201,837,254 201,837,254
Common stock, shares outstanding 201,837,254 201,837,254
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Operations and Comprehensive Income (loss) (Unaudited) - USD ($)
3 Months Ended
Nov. 30, 2017
Nov. 30, 2016
Income Statement [Abstract]    
Revenues $ 2,253,737 $ 1,818,139
Cost of revenues 1,407,693 1,164,113
Gross profit 846,044 654,026
Operating expenses:    
Selling expenses 38,139 10,301
General and administrative expenses 980,275 580,864
Total operating expenses 1,018,414 591,165
Income (loss) from operations (172,370) 62,861
Non operating income (expense)    
Interest income 51 10,978
Interest expense (134,153) (117,088)
Total other income (expense) (134,102) (106,110)
Loss before income taxes (306,472) (43,249)
Income tax expense 54,216
Net loss (360,688) (43,249)
Net loss attributed to noncontrolling interest (3,400) (1,727)
Net loss attributed to Novo Integrated Sciences, Inc. (357,288) (41,522)
Comprehensive income (loss):    
Net loss (360,688) (43,249)
Foreign currency translation gain 124,187 161,143
Comprehensive income (loss): $ (236,501) $ 117,894
Weighted average common shares outstanding - basic and diluted 201,837,254 167,797,406
Net loss per common share - basic and diluted $ (0.00) $ (0.00)
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Nov. 30, 2017
Nov. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (360,688) $ (43,249)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation 14,998 15,580
Fair value of vested stock options 142,665
Changes in operating assets and liabilities:    
Accounts receivable (197,389) (47,705)
Prepaid expenses and other current assets 54,786 20,459
Accounts payable (82,701) (19,698)
Accrued expenses 29,415 25,934
Accrued interest 47,099 83,132
Net cash provided by (used in) operating activities (351,815) 34,453
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of furniture and equipment (4,242) (14,149)
Amounts loaned for other receivables (19,351)
Repayments of other receivables 376,850
Net cash provided by (used in) investing activities (23,593) 362,701
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayments from related parties (176,804) (192,388)
Payments on notes payable (7,121) (10,097)
Net cash used in financing activities (183,925) (202,485)
Effect of exchange rate changes on cash and equivalents (41,607) (4,829)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (600,940) 189,840
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 1,896,572 110,315
CASH AND CASH EQUIVALENTS, END OF PERIOD 1,295,632 300,155
CASH PAID FOR:    
Interest 99,763 53,855
Income taxes
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Organization and Basis of Presentation
3 Months Ended
Nov. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Basis of Presentation

Note 1 - Organization and Basis of Presentation

 

Organization and Line of Business

 

Novo Integrated Sciences, Inc. was incorporated in Delaware on November 27, 2000, under the name Turbine Truck Engines, Inc. On February 20, 2008, the Company was re-domiciled to the State of Nevada. Effective July 12, 2017, the Company’s name was changed to Novo Integrated Sciences, Inc. When used herein, the terms the “Company,” “we,” “us” and “our” refer to Novo Integrated Sciences, Inc. and its consolidated subsidiaries.

 

We provide specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology and dental services to our clients. Our multi-disciplinary primary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation and prevention through our 14 corporate owned clinics, 150 affiliate clinics, retirement homes, long-term care facilities and institutional locations throughout Canada. Directly and indirectly through our contractual relationships, we provide our specialized services to over 300,000 patients annually. No employee of the Company or any of its subsidiaries practices primary care medicine and the Company’s services do not require a medical or nursing license.

 

On April 25, 2017 (the “Effective Date”), the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) by and between (i) the Company; (ii) NHL, (iii) ALMC-ASAP Holdings Inc. (“ALMC”); (iv) Michael Gaynor Family Trust (the “MGFT”); (v) 1218814 Ontario Inc. (“1218814”) and (vi) Michael Gaynor Physiotherapy Professional Corp. (“MGPP,” and together with ALMC, MGFT and 1218814, the “NHL Shareholders”). Pursuant to the terms of the Share Exchange Agreement, the Company agreed to acquire from the NHL Shareholders all of the shares of both common and preferred stock of NHL, held by the NHL Shareholders, in exchange for the issuance by the Company to the NHL Shareholders of shares of the Company’s common stock, such that following the closing of the Share Exchange Agreement, the NHL Shareholders would own 167,797,406 restricted shares of Company common stock, representing 85% of the issued and outstanding Company common stock, calculated including all granted and issued options or warrants to acquire the Company common stock as of the Effective Date, but to exclude shares of Company common stock that are subject to a then-current Regulation S offering that was undertaking by the Company (the “Exchange”).

 

On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.

 

The Exchange was accounted for as a reverse acquisition under the purchase method of accounting since NHL obtained control of Novo Integrated Sciences, Inc. Accordingly, the Exchange was recorded as a recapitalization of NHL, with NHL being treated as the continuing entity. The historical financial statements presented are the financial statements of NHL. The Share Exchange Agreement was treated as a recapitalization and not as a business combination; therefore, no pro forma information is disclosed. At the closing date of the Exchange, the net assets of the legal acquirer, Novo Integrated Sciences, Inc., were $6,904.

 

On May 9, 2017, our Board of Directors determined, in connection with the closing of the Exchange, to change our fiscal year end from December 31 to August 31, but did not memorialize such determination in writing. On July 17, 2017, the Board ratified and memorialized in writing its May 9, 2017 determination regarding the change in fiscal year end.

 

The unaudited consolidated financial statements are prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The information furnished herein reflects all adjustments, consisting only of normal recurring adjustments, which in the opinion of management, are necessary to fairly state the Company’s financial position, the results of its operations, and cash flows for the periods presented. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) were omitted pursuant to such rules and regulations. The results of operations for the three months ended November 30, 2017 are not necessarily indicative of the results for the year ending August 31, 2018.

 

Basis of Presentation

 

The accompanying consolidated financial statements were prepared in conformity with U.S. GAAP. The Company’s Canadian subsidiaries’ functional currency is the Canadian Dollar (“CAD”); however, the accompanying consolidated financial statements were translated and presented in United States Dollars (“$” or “USD”).

 

Foreign Currency Translation

 

The accounts of the Company’s Canadian subsidiaries are maintained in CAD. The accounts of these subsidiaries are translated into USD in accordance with ASC Topic 830 Foreign Currency Transaction, with the CAD as the functional currency. According to Topic 830, all assets and liabilities are translated at the exchange rate on the balance sheet date, stockholders’ equity is translated at historical rates and statement of operations items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, Comprehensive Income. Gains and losses resulting from the translations of foreign currency transactions and balances are reflected in the statement of operations and comprehensive income. The following table details the exchange rates used for the respective periods:

 

    November 30, 2017     November 30, 2016     August 31, 2017  
                   
Period end: CAD to USD exchange rate   $ 0.7761     $ 0.7447     $ 0.7988  
Average period: CAD to USD exchange rate   $ 0.7973     $ 0.7537          

XML 17 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies
3 Months Ended
Nov. 30, 2017
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, NHL, Novo Peak Health Inc., Novo Healthnet Rehab Limited, Novo Assessments Inc., an 80% interest in Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, and a fifty percent stake in a joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated as Novo Dental. All of the Company’s subsidiaries are incorporated under the laws of the Province of Ontario, Canada. All intercompany transactions have been eliminated.

 

Noncontrolling Interest

 

The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, which governs the accounting for and reporting of non-controlling interests (“NCIs”) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent’s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.

 

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

 

Cash Equivalents

 

For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less.

 

Accounts Receivable

 

Accounts receivable are recorded, net of allowance for doubtful accounts and sales returns. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentration, customer credit worthiness, current economic trends and changes in customer payment patterns to determine if the allowance for doubtful accounts is adequate. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Delinquent account balances are written-off after management has determined that the likelihood of collection is not probable and known bad debts are written off against the allowance for doubtful accounts when identified. As of November 30, 2017 and August 31, 2017, the allowance for uncollectible accounts receivable was $474,376 and $507,636, respectively.

 

Property and Equipment

 

Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:

 

Leasehold improvements 5 years
Clinical equipment 5 years
Computer equipment 3 years
Office equipment 5 years
Furniture and fixtures 5 years

 

Long-Lived Assets

 

The Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at November 30, 2017 and August 31, 2017, the Company believes there was no impairment of its long-lived assets.

 

Goodwill

 

Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. Under accounting requirements, goodwill is not amortized but is subject to annual impairment tests. The Company recorded goodwill of $388,050 at November 30, 2017 related to its acquisition of Apka Health, Inc. during fiscal year ended August 31, 2017. As of August 31, 2017, the Company performed the required impairment review. Based on its review at August 31, 2017, the Company believes there was no impairment of its goodwill.

 

Acquisition Deposits

 

The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,128,987 at November 30, 2017.

 

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash and equivalents, restricted cash, accounts receivable, advances to suppliers, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.

 

FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the fair value of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

  Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.
     
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
     
  Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the fair value measurement.

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.

 

As of November 30, 2017 and August 31, 2017, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.

 

Revenue Recognition

 

Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with FASB ASC 605, Revenue Recognition: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

 

Income Taxes

 

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.

 

Stock-Based Compensation

 

The Company records stock-based compensation in accordance with FASB ASC Topic 718, Compensation – Stock Compensation. FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at fair value at the grant date and recognize the expense over the requisite service period. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees.

 

Basic and Diluted Earnings Per Share

 

Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. There were 7,980,000 options/warrants outstanding as of November 30, 2017. Due to the net loss incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented.

 

Foreign Currency Transactions and Comprehensive Income

 

U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian $. Translation gains of $1,365,031 and $1,240,844 at November 30, 2017 and August 31, 2017, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

 

Statement of Cash Flows

 

Cash flows from the Company’s operations are calculated based upon the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.

 

Recent Accounting Pronouncements

 

In January 2017, the FASB issued an Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.

 

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company’s financial statements and disclosures.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Related Party Transactions
3 Months Ended
Nov. 30, 2017
Related Party Transactions [Abstract]  
Related Party Transactions

Note 3 – Related Party Transactions

 

Due to related parties

 

Amounts loaned to the Company by stockholders and officers of the Company that are non-interest bearing and payable upon demand.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Other Receivables
3 Months Ended
Nov. 30, 2017
Receivables [Abstract]  
Other Receivables

Note 4 – Other Receivables

 

Other receivables at November 30, 2017 and August 31, 2017 consisted of the following:

 

    November 30, 2017     August 31, 2017  
Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; due November 15, 2016.   $ -     $ 39,940  
Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 12% per annum; secured by certain assets; due May 23, 2018.     291,037       299,550  
Advance to corporation; non-interest bearing; unsecured; payable upon demand     31,044       32,534  
Advance to corporation; non-interest bearing; unsecured; payable upon demand     58,208       -  
Total other receivables   $ 380,289     $ 372,024  

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
Property and Equipment
3 Months Ended
Nov. 30, 2017
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 5 – Property and Equipment

 

Property and equipment at November 30, 2017 and August 31, 2017 consisted of the following:

 

    November 30, 2017     August 31, 2017  
Leasehold Improvements   $ 320,607     $ 329,985  
Clinical equipment     167,524       177,514  
Computer equipment     21,345       21,020  
Office equipment     23,628       24,319  
Furniture and fixtures     25,854       18,218  
      558,958       571,056  
Accumulated depreciation     (275,084 )     (268,105 )
Total   $ 283,874     $ 302,951  

 

Depreciation expense for the three months ended November 30, 2017 and 2016 was $14,998 and $15,580, respectively.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
Notes Payable
3 Months Ended
Nov. 30, 2017
Debt Disclosure [Abstract]  
Notes Payable

Note 6 – Notes Payable

 

Notes payable at November 30, 2017 and August 31, 2017 consisted of the following:

 

    November 30, 2017     August 31, 2017  
Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017. This note has been fully repaid.     -       7,134  
Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 21, 2019.     388,050       399,400  
Notes payable assumed with acquisition; accrues interest at 6% per annum; monthly principal and interest payment of $619; unsecured; due April 8, 2019.     20,391       20,988  
      408,441       427,522  
Current portion     (6,073 )     (13,171 )
Long-term portion   $ 402,368     $ 414,351  

 

Aggregate future maturities of notes payable as of November 30 are as follows:

 

Twelve months ending November 30,      
2018   $ 6,073  
2019     402,368  
    $ 408,441  

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
Debentures, Related Parties
3 Months Ended
Nov. 30, 2017
Debt Disclosure [Abstract]  
Debentures, Related Parties

Note 7 – Debentures, related parties

 

On September 30, 2013, the Company issued five debentures totaling $4,968,990 (CAD$6,402,512) at November 30, 2017 in connection with the acquisition of certain business assets. The holders of the debentures are current stockholders, officers and/or affiliates of the Company. The debentures are secured by all the assets of the Company, accrue interest at 8% per annum and were originally due on September 30, 2016. On December 2, 2017, the debenture holders agreed to extend the due date to September 30, 2019. On December 5, 2017, the debenture holders and the Company signed a binding Letter of Intent to convert no less than seventy-five percent (75%) of the debenture value plus any interest or fees owed to the Company’s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Deficit
3 Months Ended
Nov. 30, 2017
Equity [Abstract]  
Stockholders' Deficit

Note 8 – Stockholders’ Deficit

 

Convertible preferred stock

 

The Company has authorized 1,000,000 shares of $0.001 par value convertible preferred stock. At November 30, 2017 and August 31, 2017 there were 0 and 0 convertible preferred shares issued and outstanding, respectively.

 

Common stock

 

The Company has authorized 499,000,000 shares of $0.001 par value common stock. At November 30, 2017 and August 31, 2017 there were 201,837,254 and 201,837,254 common shares issued and outstanding, respectively.

 

Stock options/warrants

 

On September 8, 2015, the Company adopted the 2015 Incentive Compensation Plan (the “2015 Plan”), which authorizes the issuance of up to 5,000,000 shares of common stock to employees, officers, directors or independent consultants of the Company, provided that no person can be granted shares under the 2015 Plan for services related to raising capital or promotional activities. During 2017 and 2016, the Company did not grant any awards under the 2015 Plan. As of August 31, 2017, 4,987,500 shares were available under the 2015 Plan for future grants, awards, options or share issuances. However, because the shares issuable under the 2015 Plan or issuable upon conversion of awards granted under the Plan are no longer registered under the Securities Exchange Act of 1934, as amended, the Company does not intend to issue any additional grants under the 2015 Plan.

 

The following is a summary of stock option/warrant activity:

 

                Weighted        
          Weighted     Average        
    Options/     Average     Remaining     Aggregate  
    Warrants     Exercise     Contractual     Intrinsic  
    Outstanding     Price     Life     Value  
Outstanding, August 31, 2017     7,860,000     $ 0.266       3.53     $ 660,000  
Granted     120,000       0.400                  
Forfeited     -                          
Exercised     -                          
Outstanding, November 30, 2017     7,980,000       0.268       3.56       1,797,200  
Exercisable, November 30, 2017     6,920,000     $ 0.259       3.36     $ 1,653,600  

 

The exercise price for options/warrants outstanding at November 30, 2017:

 

Outstanding     Exercisable  
Number of           Number of        
Options/     Exercise     Options/     Exercise  
Warrants     Price     Warrants     Price  
  5,500,000     $ 0.16       5,500,000     $ 0.16  
  1,000,000       0.32       -       0.32  
  120,000       0.40       60,000       0.40  
  100,000       0.50       100,000       0.50  
  1,000,000       0.62       1,000,000       0.62  
  250,000       0.80       250,000       0.80  
  10,000       2.00       10,000       2.00  
  7,980,000               6,920,000          

 

For options granted during fiscal year 2017 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.58 and the weighted-average exercise price of such options/warrants was $0.42. No options were granted during fiscal 2017 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.

 

For options granted during fiscal year 2018 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.39 and the weighted-average exercise price of such options/warrants was $0.40. No options were granted during fiscal 2018 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.

 

The fair value of the stock options is being amortized to stock option expense over the vesting period. The Company recorded stock option expense of $142,665 during the three months ended November 30, 2017. At November 30, 2017, the unamortized stock option expense was $286,413.

 

The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:

 

Risk-free interest rate     1.5 %
Expected life of the options     2.5 years  
Expected volatility     323 %
Expected dividend yield     0 %

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments and Contingencies
3 Months Ended
Nov. 30, 2017
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 9 – Commitments and Contingencies

 

Litigation

 

The Company is party to certain legal proceedings from time to time incidental to the conduct of its business. These proceedings could result in fines, penalties, compensatory or treble damages or non-monetary relief. The nature of legal proceedings is such that the Company cannot assure the outcome of any particular matter, and an unfavorable ruling or development could have a materially adverse effect on our consolidated financial position, results of operations and cash flows in the period in which a ruling or settlement occurs. However, based on information available to the Company’s management to date, the Company’s management does not expect that the outcome of any matter pending against the Company is likely to have a materially adverse effect on the Company’s consolidated financial position as of November 30, 2017, results of operations, cash flows or liquidity of the Company.

 

Leases

 

The Company leases its office space and certain facilities under long-term operating leases expiring through fiscal year 2023. Rent expense under these leases was $191,940 and $193,501 for the three months ended November 30, 2017 and 2016, respectively.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Subsequent Events
3 Months Ended
Nov. 30, 2017
Subsequent Events [Abstract]  
Subsequent Events

Note 10 – Subsequent Events

 

On December 1, 2017, the Company and Executive Fitness Leaders, located in Ottawa Ontario Canada, entered into an Asset Purchase Agreement, pursuant to which the Company acquired substantially all of the assets of Executive Fitness Leaders in exchange for the issuance, by the Company, of 384,110 restricted shares of its common stock valued at approximately $233,155. The transaction closed on December 1, 2017. The purchase of these assets was not considered significant for accounting purposes; therefore, pro forma financial statements are not presented.

 

On December 2, 2017, the Company and certain related party debenture holders of five debentures totaling $4,968,990 (CAD$6,402,512) dated September 30, 2013 with an original due date of September 30, 2016 (see Note 7 for further details) agreed to extend the due date of the debentures to September 30, 2019.

 

On December 5, 2017, the related party debenture holders and the Company signed a binding Letter of Intent to convert no less than 75% of the debenture value, plus any interest or fees owed, to the Company’s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five trading days immediately preceding the date of conversion with a 10% premium added to the calculated per share price.

 

On December 26, 2017, the Company entered into a binding letter of intent (the “LOI”) with Brands International Corporation (“Brands”), pursuant to which the Company agreed to acquire 60% of the issued and outstanding shares of Brands in exchange for the arrangement of secured debt financing in the amount of CAD$2,350,000 (approximately $1,873,256 per the Bank of Canada posted exchange rate of 0.7977 on December 29, 2017) arranged or provided by the Company (the “Acquisition”). Upon completion of the Acquisition, the Company will own 60% of Brands’ issued and outstanding shares and Brands will be a partially-owned subsidiary of the Company. In connection with the Acquisition, the Company will enter into a shareholder agreement with Mark Rubinoff and a management agreement with Mark Rubinoff and DJ Robinoff. In addition, pursuant to the terms of the LOI, the Company agreed to provide Mark Rubinoff with a buyout structure for the remaining 40% of Brands’ shares with a trigger date of 24 months from the closing of the Acquisition.

 

The parties to the LOI agreed to proceed reasonably and in good faith toward negotiation and execution of a definitive acquisition agreement (a “Definitive Agreement”), and to use their commercially reasonable best efforts to obtain necessary board, stockholder and regulatory approvals and third party consents.

 

The parties to the LOI also agreed that from the date of the LOI until the earlier of January 30, 2018 (the “Termination Date”) and the date the parties enter into a Definitive Agreement, the parties and their respective directors, officers, agents and representatives will not:

 

  solicit, initiate or encourage the initiation of any expression of interest, inquiries or proposals regarding, constituting or that may reasonably be expected to lead to any merger, amalgamation, takeover bid, tender offer, arrangement, recapitalization, liquidations, dissolution, share exchange, sale of material assets involving the parties or a proposal or offer to do so (the “Acquisition Proposal”) (including without limitation, any grant of an option or other right to take any such action);
     
  participate in any discussions or negotiations regarding an Acquisition Proposal;
     
  accept or enter into, or propose publicly to accept or enter into, any agreement, letter of intent, memorandum of understanding or any arrangement in respect of an Acquisition Proposal; and
     
  otherwise cooperate in any way, assist or participate in, facilitate or encourage any effort or attempt by any person to do any of the foregoing.

 

In addition, Brands agreed not to solicit funds in any secured or unsecured debt form resulting in a change in the company’s financials unless the Company is made aware of such solicitation in writing.

 

If the Definitive Agreement is not negotiated and executed by both parties on or before the Termination Date, or such other date as agreed to by the parties in writing, the terms of the LOI will be of no further force or effect except for the confidentiality, costs and governing laws provisions, which sections will remain in effect for a period of one year following the date on which the LOI is terminated.

 

On December 29, 2017, the Company entered into an employment agreement (the “Employment Agreement”) with Christopher David, the Company’s President and a member of the board of directors, effective January 1, 2018. The Employment Agreement terminates on July 30, 2018, subject to the termination provisions contained in the Employment Agreement.

 

Pursuant to the terms of the Employment Agreement, Mr. David agreed to serve as the Company’s President. In consideration thereof, the Company agreed to (i) pay Mr. David a monthly salary of $8,000, and (ii) grant Mr. David a 5-year option (the “Option”) to purchase 2,000,000 shares of the Company’s restricted common stock at an exercise price of $0.42 per share. The Option vested on December 29, 2017.

 

Pursuant to the terms of the Employment Agreement, the Company may terminate Mr. David at any time, with or without Cause (as defined below); provided, however, that if the Company terminates Mr. David without Cause:

 

(a) The Option shall be deemed fully vested effective as of December 29, 2017, and is not subject to revocation or return, and

 

(b) The Company will continue to owe Mr. David his monthly salary through July 30, 2018.

 

“Cause” means Mr. David must have (i) been willful, gross or persistent in his inattention to his duties or he committed acts which constitute willful or gross misconduct and, after written notice of the same, has been given the opportunity to cure the same within 30 days after such notice, and (ii) been found guilty of having committed a fraud against the Company.

 

On December 29, 2017, the Company granted the Option to Mr. David pursuant to that certain Option to Purchase Common Stock (the “Option Agreement”). The Option Agreement provides for the cashless exercise of all or a portion of the Option, or exercise through payment of the exercise price in cash.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Nov. 30, 2017
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Principles of Consolidation

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, NHL, Novo Peak Health Inc., Novo Healthnet Rehab Limited, Novo Assessments Inc., an 80% interest in Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, and a fifty percent stake in a joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated as Novo Dental. All of the Company’s subsidiaries are incorporated under the laws of the Province of Ontario, Canada. All intercompany transactions have been eliminated.

Noncontrolling Interest

Noncontrolling Interest

 

The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, which governs the accounting for and reporting of non-controlling interests (“NCIs”) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent’s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.

 

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

Cash Equivalents

Cash Equivalents

 

For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less.

Accounts Receivable

Accounts Receivable

 

Accounts receivable are recorded, net of allowance for doubtful accounts and sales returns. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentration, customer credit worthiness, current economic trends and changes in customer payment patterns to determine if the allowance for doubtful accounts is adequate. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Delinquent account balances are written-off after management has determined that the likelihood of collection is not probable and known bad debts are written off against the allowance for doubtful accounts when identified. As of November 30, 2017 and August 31, 2017, the allowance for uncollectible accounts receivable was $474,376 and $507,636, respectively.

Property and Equipment

Property and Equipment

 

Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:

 

Leasehold improvements 5 years
Clinical equipment 5 years
Computer equipment 3 years
Office equipment 5 years
Furniture and fixtures 5 years

Long-lived Assets

Long-Lived Assets

 

The Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at November 30, 2017 and August 31, 2017, the Company believes there was no impairment of its long-lived assets.

Goodwill

Goodwill

 

Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. Under accounting requirements, goodwill is not amortized but is subject to annual impairment tests. The Company recorded goodwill of $388,050 at November 30, 2017 related to its acquisition of Apka Health, Inc. during fiscal year ended August 31, 2017. As of August 31, 2017, the Company performed the required impairment review. Based on its review at August 31, 2017, the Company believes there was no impairment of its goodwill.

Acquisition Deposits

Acquisition Deposits

 

The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,128,987 at November 30, 2017.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash and equivalents, restricted cash, accounts receivable, advances to suppliers, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.

 

FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the fair value of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

  Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.
     
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
     
  Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the fair value measurement.

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.

 

As of November 30, 2017 and August 31, 2017, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.

Revenue Recognition

Revenue Recognition

 

Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with FASB ASC 605, Revenue Recognition: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

Income Taxes

Income Taxes

 

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.

Stock-Based Compensation

Stock-Based Compensation

 

The Company records stock-based compensation in accordance with FASB ASC Topic 718, Compensation – Stock Compensation. FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at fair value at the grant date and recognize the expense over the requisite service period. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees.

Basic and Diluted Earnings Per Share

Basic and Diluted Earnings Per Share

 

Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. There were 7,980,000 options/warrants outstanding as of November 30, 2017. Due to the net loss incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented.

Foreign Currency Transactions and Comprehensive Income

Foreign Currency Transactions and Comprehensive Income

 

U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian $. Translation gains of $1,365,031 and $1,240,844 at November 30, 2017 and August 31, 2017, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

Statement of Cash Flows

Statement of Cash Flows

 

Cash flows from the Company’s operations are calculated based upon the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In January 2017, the FASB issued an Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.

 

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

 

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company’s financial statements and disclosures.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Organization and Basis of Presentation (Tables)
3 Months Ended
Nov. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Foreign Currency Translation, Exchange Rate Used

The following table details the exchange rates used for the respective periods:

 

    November 30, 2017     November 30, 2016     August 31, 2017  
                   
Period end: CAD to USD exchange rate   $ 0.7761     $ 0.7447     $ 0.7988  
Average period: CAD to USD exchange rate   $ 0.7973     $ 0.7537          

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Nov. 30, 2017
Accounting Policies [Abstract]  
Schedule of Estimated Useful Lives of Assets

Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:

 

Leasehold improvements 5 years
Clinical equipment 5 years
Computer equipment 3 years
Office equipment 5 years
Furniture and fixtures 5 years

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Other Receivables (Tables)
3 Months Ended
Nov. 30, 2017
Receivables [Abstract]  
Schedule of Other Receivables

Other receivables at November 30, 2017 and August 31, 2017 consisted of the following:

 

    November 30, 2017     August 31, 2017  
Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; due November 15, 2016.   $ -     $ 39,940  
Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 12% per annum; secured by certain assets; due May 23, 2018.     291,037       299,550  
Advance to corporation; non-interest bearing; unsecured; payable upon demand     31,044       32,534  
Advance to corporation; non-interest bearing; unsecured; payable upon demand     58,208       -  
Total other receivables   $ 380,289     $ 372,024  

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Property and Equipment (Tables)
3 Months Ended
Nov. 30, 2017
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Property and equipment at November 30, 2017 and August 31, 2017 consisted of the following:

 

    November 30, 2017     August 31, 2017  
Leasehold Improvements   $ 320,607     $ 329,985  
Clinical equipment     167,524       177,514  
Computer equipment     21,345       21,020  
Office equipment     23,628       24,319  
Furniture and fixtures     25,854       18,218  
      558,958       571,056  
Accumulated depreciation     (275,084 )     (268,105 )
Total   $ 283,874     $ 302,951  

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Notes Payable (Tables)
3 Months Ended
Nov. 30, 2017
Debt Disclosure [Abstract]  
Schedule of Notes Payable

Notes payable at November 30, 2017 and August 31, 2017 consisted of the following:

 

    November 30, 2017     August 31, 2017  
Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017. This note has been fully repaid.     -       7,134  
Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 21, 2019.     388,050       399,400  
Notes payable assumed with acquisition; accrues interest at 6% per annum; monthly principal and interest payment of $619; unsecured; due April 8, 2019.     20,391       20,988  
      408,441       427,522  
Current portion     (6,073 )     (13,171 )
Long-term portion   $ 402,368     $ 414,351  

Schedule of Future Maturities of Notes Payable

Aggregate future maturities of notes payable as of November 30 are as follows:

 

Twelve months ending November 30,      
2018   $ 6,073  
2019     402,368  
    $ 408,441  

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Deficit (Tables)
3 Months Ended
Nov. 30, 2017
Equity [Abstract]  
Schedule of Stock Option and Warrant Activity

The following is a summary of stock option/warrant activity:

 

                Weighted        
          Weighted     Average        
    Options/     Average     Remaining     Aggregate  
    Warrants     Exercise     Contractual     Intrinsic  
    Outstanding     Price     Life     Value  
Outstanding, August 31, 2017     7,860,000     $ 0.266       3.53     $ 660,000  
Granted     120,000       0.400                  
Forfeited     -                          
Exercised     -                          
Outstanding, November 30, 2017     7,980,000       0.268       3.56       1,797,200  
Exercisable, November 30, 2017     6,920,000     $ 0.259       3.36     $ 1,653,600  

Schedule of Options and Warrants Outstanding and Exercisable

The exercise price for options/warrants outstanding at November 30, 2017:

 

Outstanding     Exercisable  
Number of           Number of        
Options/     Exercise     Options/     Exercise  
Warrants     Price     Warrants     Price  
  5,500,000     $ 0.16       5,500,000     $ 0.16  
  1,000,000       0.32       -       0.32  
  120,000       0.40       60,000       0.40  
  100,000       0.50       100,000       0.50  
  1,000,000       0.62       1,000,000       0.62  
  250,000       0.80       250,000       0.80  
  10,000       2.00       10,000       2.00  
  7,980,000               6,920,000          

Schedule of Fair Value of Options Granted by Using Valuation Assumptions

The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:

 

Risk-free interest rate     1.5 %
Expected life of the options     2.5 years  
Expected volatility     323 %
Expected dividend yield     0 %

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Organization and Basis of Presentation (Details Narrative) - USD ($)
3 Months Ended
Apr. 25, 2017
Nov. 30, 2017
Common stock issued in connection with reverse merger transaction   $ 6,904
Turbine Truck Engines, Inc [Member]    
State country name   Delaware
Date of incorporation   Nov. 27, 2000
Turbine Truck Engines, Inc One [Member]    
State country name   State of Nevada
Date of incorporation   Feb. 20, 2008
NHL [Member] | Share Exchange Agreement [Member]    
Number of restricted shares of common stock 167,797,406  
Percentage of common stock issued and outstanding 85.00%  
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) - CAD [Member]
Nov. 30, 2017
Aug. 31, 2017
Nov. 30, 2016
Period End [Member]      
Foreign currency exchange rate 0.7761 0.7988 0.7447
Average Period [Member]      
Foreign currency exchange rate 0.7973   0.7537
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Nov. 30, 2017
Aug. 31, 2017
Allowance for uncollectible accounts receivable $ 474,376 $ 507,636
Goodwill 388,050 399,400
Acquisition deposits $ 1,128,987 1,162,009
Potentially dilutive common stock options and warrants outstanding, shares 7,980,000  
Gain on foreign currency transactions $ 1,365,031 $ 1,240,844
Novo Healthnet Kemptville Centre, Inc [Member]    
Equity method investment, ownership percentage 80.00%  
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details)
3 Months Ended
Nov. 30, 2017
Leasehold Improvements [Member]  
Property and equipment, estimated lives 5 years
Clinical Equipment [Member]  
Property and equipment, estimated lives 5 years
Computer Equipment [Member]  
Property and equipment, estimated lives 3 years
Office Equipment [Member]  
Property and equipment, estimated lives 5 years
Furniture and Fixtures [Member]  
Property and equipment, estimated lives 5 years
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Other Receivables - Schedule of Other Receivables (Details) - USD ($)
Nov. 30, 2017
Aug. 31, 2017
Total other receivables $ 380,289 $ 372,024
Notes Receivable Dated November 15, 2014 [Member]    
Total other receivables 39,940
Notes Receivable Dated April 1, 2015 and May 23, 2017 [Member]    
Total other receivables 291,037 299,550
Advance to Corporation One [Member]    
Total other receivables 31,044 32,534
Advance to Corporation Two [Member]    
Total other receivables $ 58,208
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Other Receivables - Schedule of Other Receivables (Details) (Parenthetical)
3 Months Ended 12 Months Ended
Nov. 30, 2017
Aug. 31, 2017
Notes Receivable Dated November 15, 2014 [Member]    
Percentage of accrues interest per annum 8.00% 8.00%
Notes receivable due date Nov. 15, 2016 Nov. 15, 2016
Notes Receivable Dated April 1, 2015 and May 23, 2017 [Member]    
Percentage of accrues interest per annum 12.00% 12.00%
Notes receivable due date May 23, 2018 May 23, 2018
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Property and Equipment (Details Narrative) - USD ($)
3 Months Ended
Nov. 30, 2017
Nov. 30, 2016
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 14,998 $ 15,580
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)
Nov. 30, 2017
Aug. 31, 2017
Property and equipment, gross $ 558,958 $ 571,056
Accumulated depreciation (275,084) (268,105)
Total 283,874 302,951
Leasehold Improvements [Member]    
Property and equipment, gross 320,607 329,985
Clinical Equipment [Member]    
Property and equipment, gross 167,524 177,514
Computer Equipment [Member]    
Property and equipment, gross 21,345 21,020
Office Equipment [Member]    
Property and equipment, gross 23,628 24,319
Furniture and Fixtures [Member]    
Property and equipment, gross $ 25,854 $ 18,218
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Notes Payable - Schedule of Notes Payable (Details) - USD ($)
Nov. 30, 2017
Aug. 31, 2017
Note payable $ 408,441 $ 427,522
Current portion (6,073) (13,171)
Long-term portion 402,368 414,351
Note Payable One [Member]    
Note payable 7,134
Note Payable Two [Member]    
Note payable 388,050 399,400
Note Payable Three [Member]    
Note payable $ 20,391 $ 20,988
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) - USD ($)
3 Months Ended 12 Months Ended
Nov. 30, 2017
Aug. 31, 2017
Notes payable, due date Sep. 30, 2016  
Note Payable One [Member]    
Percentage of accrues interest per annum 7.20% 7.20%
Notes payable, due date Oct. 31, 2017 Oct. 31, 2017
Debt periodic payment $ 3,567 $ 3,567
Note Payable Two [Member]    
Percentage of accrues interest per annum 0.00% 0.00%
Notes payable, due date Mar. 21, 2019 Mar. 21, 2019
Note Payable Three [Member]    
Percentage of accrues interest per annum 6.00% 6.00%
Notes payable, due date Apr. 08, 2019 Apr. 08, 2019
Debt periodic payment $ 619 $ 619
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Notes Payable - Schedule of Future Maturities of Notes Payable (Details)
Nov. 30, 2017
USD ($)
Debt Disclosure [Abstract]  
2018 $ 6,073
2019 402,368
Total $ 408,441
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Debentures, Related Parties (Details Narrative)
3 Months Ended
Nov. 30, 2017
CAD
Sep. 30, 2013
USD ($)
Debt interest rate 8.00%  
Debt due date Sep. 30, 2016  
Debt conversion description The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.  
December 2, 2017 [Member]    
Debt extended due date Sep. 30, 2019  
December 5, 2017 [Member] | Maximum [Member]    
Debt interest rate 75.00%  
Five Debentures [Member]    
Debentures, related parties | $   $ 4,968,990
Five Debentures [Member] | CAD [Member]    
Debentures, related parties | CAD CAD 6,402,512  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders’ Deficit (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Sep. 08, 2015
Nov. 30, 2017
Aug. 31, 2017
Convertible Preferred stock shares authorized   1,000,000 1,000,000
Convertible Preferred stock par value   $ 0.001 $ 0.001
Convertible Preferred stock shares issued   0 0
Convertible Preferred stock shares outstanding   0 0
Common stock shares authorized   499,000,000 499,000,000
Common stock par value   $ 0.001 $ 0.001
Common stock shares issued   201,837,254 201,837,254
Common stock shares outstanding   201,837,254 201,837,254
Stock options granted weighted-average grant date fair value   $ 0.58  
Stock options/warrants weighted-average exercise   $ 0.42  
Stock option expense   $ 142,665  
Unamortized stock option expense   $ 286,413  
2018 [Member]      
Stock options granted weighted-average grant date fair value   $ 0.39  
Stock options/warrants weighted-average exercise   $ 0.40  
2015 Incentive Compensation Plan [Member]      
Number of shares issued for granted     4,987,500
2015 Incentive Compensation Plan [Member] | Maximum [Member]      
Number of common stock shares issued 5,000,000    
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders’ Deficit - Schedule of Stock Option and Warrant Activity (Details)
3 Months Ended
Nov. 30, 2017
USD ($)
$ / shares
shares
Equity [Abstract]  
Options/Warrants Outstanding, Beginning balance 7,860,000
Options/Warrants Outstanding, Granted 120,000
Options/Warrants Outstanding, Forfeited
Options/Warrants Outstanding, Exercised
Options/Warrants Outstanding, Ending balance 7,980,000
Options/Warrants Outstanding, Exercisable 6,920,000
Weighted Average Exercise Price, Beginning balance | $ / shares $ 0.266
Weighted Average Exercise Price, Granted | $ / shares 0.400
Weighted Average Exercise Price, Ending balance | $ / shares 0.268
Weighted Average Exercise Price, Exercisable | $ / shares $ 0.259
Weighted Average Remaining Contractual Life, Outstanding, Beginning balance 3 years 6 months 10 days
Weighted Average Remaining Contractual Life, Outstanding, Ending balance 3 years 6 months 21 days
Weighted Average Remaining Contractual Life, Exercisable 3 years 4 months 9 days
Aggregate Intrinsic Value, Outstanding, Beginning balance | $ $ 660,000
Aggregate Intrinsic Value, Outstanding, Ending balance | $ 1,797,200
Aggregate Intrinsic Value, Exercisable | $ $ 1,653,600
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders’ Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details)
Nov. 30, 2017
$ / shares
shares
Number of Options/Warrants, Outstanding 7,980,000
Number of Options/Warrants, Exercisable 6,920,000
Exercise Price Range One [Member]  
Number of Options/Warrants, Outstanding 5,500,000
Number of Options/Warrants, Outstanding, Exercise Price | $ / shares $ 0.16
Number of Options/Warrants, Exercisable 5,500,000
Number of Options/Warrants, Exercisable, Exercise Price | $ / shares $ 0.16
Exercise Price Range Two [Member]  
Number of Options/Warrants, Outstanding 1,000,000
Number of Options/Warrants, Outstanding, Exercise Price | $ / shares $ 0.32
Number of Options/Warrants, Exercisable
Number of Options/Warrants, Exercisable, Exercise Price | $ / shares $ 0.32
Exercise Price Range Three [Member]  
Number of Options/Warrants, Outstanding 120,000
Number of Options/Warrants, Outstanding, Exercise Price | $ / shares $ 0.40
Number of Options/Warrants, Exercisable 60,000
Number of Options/Warrants, Exercisable, Exercise Price | $ / shares $ 0.40
Exercise Price Range Four [Member]  
Number of Options/Warrants, Outstanding 100,000
Number of Options/Warrants, Outstanding, Exercise Price | $ / shares $ 0.50
Number of Options/Warrants, Exercisable 100,000
Number of Options/Warrants, Exercisable, Exercise Price | $ / shares $ 0.50
Exercise Price Range Five [Member]  
Number of Options/Warrants, Outstanding 1,000,000
Number of Options/Warrants, Outstanding, Exercise Price | $ / shares $ 0.62
Number of Options/Warrants, Exercisable 1,000,000
Number of Options/Warrants, Exercisable, Exercise Price | $ / shares $ 0.62
Exercise Price Range Six [Member]  
Number of Options/Warrants, Outstanding 250,000
Number of Options/Warrants, Outstanding, Exercise Price | $ / shares $ 0.80
Number of Options/Warrants, Exercisable 250,000
Number of Options/Warrants, Exercisable, Exercise Price | $ / shares $ 0.80
Exercise Price Range Seven [Member]  
Number of Options/Warrants, Outstanding 10,000
Number of Options/Warrants, Outstanding, Exercise Price | $ / shares $ 2.00
Number of Options/Warrants, Exercisable 10,000
Number of Options/Warrants, Exercisable, Exercise Price | $ / shares $ 2.00
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders’ Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details)
3 Months Ended
Nov. 30, 2017
Equity [Abstract]  
Risk-free interest rate 1.50%
Expected life of the options 2 years 6 months
Expected volatility 323.00%
Expected dividend yield 0.00%
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments and Contingencies (Details Narrative) - USD ($)
3 Months Ended
Nov. 30, 2017
Nov. 30, 2016
Commitments and Contingencies Disclosure [Abstract]    
Operating leases expiration date 2023  
Rent expense $ 191,940 $ 193,501
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
Subsequent Events (Details Narrative)
3 Months Ended
Dec. 29, 2017
USD ($)
$ / shares
shares
Dec. 26, 2017
USD ($)
Dec. 05, 2017
Dec. 02, 2017
USD ($)
Dec. 01, 2017
USD ($)
shares
Nov. 30, 2017
CAD
$ / shares
shares
Dec. 26, 2017
CAD
Dec. 02, 2017
CAD
Sep. 30, 2013
USD ($)
Debt due date           Sep. 30, 2016      
Debt interest rate           8.00%      
Debt conversion description           The per share price to be used for the conversion of each debenture will be the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.      
Number of options granted to purchase shares of common stock | shares           120,000      
Stock option exercise price | $ / shares           $ 0.400      
Five Debentures [Member]                  
Debentures, related parties                 $ 4,968,990
Five Debentures [Member] | CAD [Member]                  
Debentures, related parties | CAD           $ 6,402,512      
Subsequent Event [Member]                  
Debt due date       Sep. 30, 2016          
Debt extended due date       Sep. 30, 2019          
Debt interest rate     75.00%            
Debt conversion description     The per share price to be used for the conversion of each debenture will be the average price of the five trading days immediately preceding the date of conversion with a 10% premium added to the calculated per share price.            
Subsequent Event [Member] | Brands International Corporation [Member]                  
Debentures, related parties   $ 1,873,256              
Percentage acquired for issued and outstanding shares 60.00%                
Bank exchange rate, description Bank of Canada posted exchange rate of 0.7977 on December 29, 2017                
Subsequent Event [Member] | CAD [Member] | Brands International Corporation [Member]                  
Debentures, related parties | CAD             CAD 2,350,000    
Subsequent Event [Member] | Five Debentures [Member]                  
Debentures, related parties       $ 4,968,990          
Subsequent Event [Member] | Five Debentures [Member] | CAD [Member]                  
Debentures, related parties | CAD               CAD 6,402,512  
Subsequent Event [Member] | Asset Purchase Agreement [Member]                  
Number of restricted shares issued | shares         384,110        
Number of restricted shares issued value         $ 233,155        
Subsequent Event [Member] | Shareholder Agreement [Member] | Mark Rubinoff [Member]                  
Percentage acquired for issued and outstanding shares   40.00%              
Subsequent Event [Member] | Employment Agreement [Member]                  
Monthly salary $ 8,000                
Option term 5 years                
Number of options granted to purchase shares of common stock | shares 2,000,000                
Stock option exercise price | $ / shares $ 0.42                
EXCEL 51 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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

  •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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 53 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 55 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 80 179 1 false 39 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://novointegrated.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://novointegrated.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://novointegrated.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (loss) (Unaudited) Sheet http://novointegrated.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss Condensed Consolidated Statements of Operations and Comprehensive Income (loss) (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://novointegrated.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - Organization and Basis of Presentation Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentation Organization and Basis of Presentation Notes 6 false false R7.htm 00000007 - Disclosure - Summary of Significant Accounting Policies Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Related Party Transactions Sheet http://novointegrated.com/role/RelatedPartyTransactions Related Party Transactions Notes 8 false false R9.htm 00000009 - Disclosure - Other Receivables Sheet http://novointegrated.com/role/OtherReceivables Other Receivables Notes 9 false false R10.htm 00000010 - Disclosure - Property and Equipment Sheet http://novointegrated.com/role/PropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 00000011 - Disclosure - Notes Payable Notes http://novointegrated.com/role/NotesPayable Notes Payable Notes 11 false false R12.htm 00000012 - Disclosure - Debentures, Related Parties Sheet http://novointegrated.com/role/DebenturesRelatedParties Debentures, Related Parties Notes 12 false false R13.htm 00000013 - Disclosure - Stockholders' Deficit Sheet http://novointegrated.com/role/StockholdersDeficit Stockholders' Deficit Notes 13 false false R14.htm 00000014 - Disclosure - Commitments and Contingencies Sheet http://novointegrated.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 00000015 - Disclosure - Subsequent Events Sheet http://novointegrated.com/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 00000016 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - Organization and Basis of Presentation (Tables) Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentationTables Organization and Basis of Presentation (Tables) Tables http://novointegrated.com/role/OrganizationAndBasisOfPresentation 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 00000019 - Disclosure - Other Receivables (Tables) Sheet http://novointegrated.com/role/OtherReceivablesTables Other Receivables (Tables) Tables http://novointegrated.com/role/OtherReceivables 19 false false R20.htm 00000020 - Disclosure - Property and Equipment (Tables) Sheet http://novointegrated.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://novointegrated.com/role/PropertyAndEquipment 20 false false R21.htm 00000021 - Disclosure - Notes Payable (Tables) Notes http://novointegrated.com/role/NotesPayableTables Notes Payable (Tables) Tables http://novointegrated.com/role/NotesPayable 21 false false R22.htm 00000022 - Disclosure - Stockholders' Deficit (Tables) Sheet http://novointegrated.com/role/StockholdersDeficitTables Stockholders' Deficit (Tables) Tables http://novointegrated.com/role/StockholdersDeficit 22 false false R23.htm 00000023 - Disclosure - Organization and Basis of Presentation (Details Narrative) Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentationDetailsNarrative Organization and Basis of Presentation (Details Narrative) Details http://novointegrated.com/role/OrganizationAndBasisOfPresentationTables 23 false false R24.htm 00000024 - Disclosure - Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentation-ScheduleOfForeignCurrencyTranslationExchangeRateUsedDetails Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) Details 24 false false R25.htm 00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 00000026 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEstimatedUsefulLivesOfAssetsDetails Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) Details 26 false false R27.htm 00000027 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) Sheet http://novointegrated.com/role/OtherReceivables-ScheduleOfOtherReceivablesDetails Other Receivables - Schedule of Other Receivables (Details) Details 27 false false R28.htm 00000028 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) (Parenthetical) Sheet http://novointegrated.com/role/OtherReceivables-ScheduleOfOtherReceivablesDetailsParenthetical Other Receivables - Schedule of Other Receivables (Details) (Parenthetical) Details 28 false false R29.htm 00000029 - Disclosure - Property and Equipment (Details Narrative) Sheet http://novointegrated.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://novointegrated.com/role/PropertyAndEquipmentTables 29 false false R30.htm 00000030 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) Sheet http://novointegrated.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails Property and Equipment - Schedule of Property and Equipment (Details) Details 30 false false R31.htm 00000031 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) Notes http://novointegrated.com/role/NotesPayable-ScheduleOfNotesPayableDetails Notes Payable - Schedule of Notes Payable (Details) Details 31 false false R32.htm 00000032 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) Notes http://novointegrated.com/role/NotesPayable-ScheduleOfNotesPayableDetailsParenthetical Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) Details 32 false false R33.htm 00000033 - Disclosure - Notes Payable - Schedule of Future Maturities of Notes Payable (Details) Notes http://novointegrated.com/role/NotesPayable-ScheduleOfFutureMaturitiesOfNotesPayableDetails Notes Payable - Schedule of Future Maturities of Notes Payable (Details) Details 33 false false R34.htm 00000034 - Disclosure - Debentures, Related Parties (Details Narrative) Sheet http://novointegrated.com/role/DebenturesRelatedPartiesDetailsNarrative Debentures, Related Parties (Details Narrative) Details http://novointegrated.com/role/DebenturesRelatedParties 34 false false R35.htm 00000035 - Disclosure - Stockholders??? Deficit (Details Narrative) Sheet http://novointegrated.com/role/StockholdersDeficitDetailsNarrative Stockholders??? Deficit (Details Narrative) Details 35 false false R36.htm 00000036 - Disclosure - Stockholders??? Deficit - Schedule of Stock Option and Warrant Activity (Details) Sheet http://novointegrated.com/role/StockholdersDeficit-ScheduleOfStockOptionAndWarrantActivityDetails Stockholders??? Deficit - Schedule of Stock Option and Warrant Activity (Details) Details 36 false false R37.htm 00000037 - Disclosure - Stockholders??? Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details) Sheet http://novointegrated.com/role/StockholdersDeficit-ScheduleOfOptionsAndWarrantsOutstandingAndExercisableDetails Stockholders??? Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details) Details 37 false false R38.htm 00000038 - Disclosure - Stockholders??? Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details) Sheet http://novointegrated.com/role/StockholdersDeficit-ScheduleOfFairValueOfOptionsGrantedByUsingValuationAssumptionsDetails Stockholders??? Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details) Details 38 false false R39.htm 00000039 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://novointegrated.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://novointegrated.com/role/CommitmentsAndContingencies 39 false false R40.htm 00000040 - Disclosure - Subsequent Events (Details Narrative) Sheet http://novointegrated.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://novointegrated.com/role/SubsequentEvents 40 false false All Reports Book All Reports nvos-20171130.xml nvos-20171130.xsd nvos-20171130_cal.xml nvos-20171130_def.xml nvos-20171130_lab.xml nvos-20171130_pre.xml http://xbrl.sec.gov/currency/2017-01-31 http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 57 0001493152-18-000494-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-18-000494-xbrl.zip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end